cardioКардиологияKardiologiia0022-90402412-5660Kardiomag10.18087/cardio.2020.12.n1427cardio-1427Research ArticleМНЕНИЕ ЭКСПЕРТОВOPINION OF EXPERTSЭкспертное мнение по применению диуретиков при хронической сердечной недостаточности. Общество специалистов по сердечной недостаточностиThe use of diuretics in chronic heart failure. Position paper of the Russian Heart Failure Societyhttps://orcid.org/0000-0002-7285-2048МареевВ. Ю.MareevV. Yu.

Главный научный сотрудник

Chief Researcher Medical Research and Education Center of Moscow State University M.V. Lomonosova, Moscow, Russia

prof_mareev@ossn.ruГарганееваА. А.GarganeevaA. A.

заведующая отделением общеклинической кардиологии и эпидемиологии сердечно-сосудистых заболеваний

Head of the Department of General Clinical Cardiology and Epidemiology of Cardiovascular Diseases

 

 

aag@cardio-tomsk.ruhttps://orcid.org/0000-0003-4369-1393АгеевФ. Т.AgeevF. T.

Руководитель научно-диспансерного отдела

Head of the Scientific Dispensary Department

ftageev@gmail.comАрутюновГ. П.ArutunovG. P.

заведующий кафедрой внутренних болезней и общей физиотерапии педиатрического факультета

Head of the Department of Internal Medicine and General Physiotherapy of the Pediatric Faculty

 

arut@ossn.ruhttps://orcid.org/0000-0001-7992-6081БеграмбековаЮ. Л.BegrambekovaYu. L.

Ведущий научный сотрудник

Leading Researcher Medical Research and Education Center of Moscow State University M.V. Lomonosova

julia.begrambekova@ossn.ruhttps://orcid.org/0000-0002-3014-6129БеленковЮ. Н.BelenkovYu. N.

Директор Клиники госпитальной терапии имени Остроумова

Director of the Ostroumov Clinic of Hospital Therapy

 

belenkovyn@gmail.comhttps://orcid.org/0000-0003-2913-9797ВасюкЮ. А.VasyukYu. A.

заведующий кафедрой госпитальной терапии №1

Head of the Department of Hospital Therapy No. 1

 

yvasyuk@yandex.ruhttps://orcid.org/0000-0002-4510-6197ГалявичА. С.GalyavichA. S.

заведующий кафедрой факультетской терапии и кардиологии

 

 Head of the Department of Faculty Therapy and Cardiology

agalyavich@mail.ruГиляревскийС. Р.GilarevskyS. R.

профессор кафедры клинической фармакологии и терапии

Professor of the Department of Clinical Pharmacology and Therapy

sgilarevsky@rambler.ruГлезерМ. Г.GlezerM. G.

Professor at the Department of Preventive and Emergency Cardiology

287ast@mail.ruhttps://orcid.org/0000-0002-4453-8430ДрапкинаО. М.DrapkinaO. M.

Директор

Director

drapkina@bk.ruhttps://orcid.org/0000-0002-6453-2976ДупляковД. В.DuplyakovD. V.

заместитель главного врача по медицинской части

Deputy Chief Physician for Medical Affair

duplyakov@yahoo.comhttps://orcid.org/0000-0002-5873-1768КобалаваЖ. Д.KobalavaZh. D.

Head of the Department of Internal Medicine and Clinical Pharmacology, Faculty of Advanced Training of Medical Workers

zkobalava@mail.ruhttps://orcid.org/0000-0001-7003-5186КозиоловаН. А.KoziolovaN. A.

Head of the Department of Propedeutics of Internal Diseases No. 2

nakoziolova@mail.ruhttps://orcid.org/0000-0002-8070-2234КужелеваЕ. А.KuzhelevaE. A.

научный сотрудник

snigireva1209@rambler.ruМареевЮ. В.MareevYu. V.

старший научный сотрудник

mareev84@gmail.comОвчинниковА. Г.OvchinnikovA. G.

доктор медицинских наук, ведущий научный сотрудник Отдела амбулаторных лечеб-но-диагностических технологий, Институт клинической кардиологии им. А.Л. Мяс-никова, ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава РФ, Москва; профессор кафедры клинической функциональной диагно-стики ФГБОУ ВО «Московский государственный медико-стоматологический уни-верситет им. А.И. Евдокимова, Москва

artcardio@mail.ruhttps://orcid.org/0000-0002-8160-5612ОрловаЯ. А.OrlovaYa. A.

Заведующий отделом возраст-ассоциированных заболеваний

Head of the Department of Age-Associated Diseases Medical Research Center of Moscow State University M.V. Lomonosova

5163002@bk.ruhttps://orcid.org/0000-0003-4057-5813ПерепечН. Б.PerepechN. B.

директор Научно-клинического и образовательного Центра «Кардиология» Института высоких медицинских технологий медицинского факультета

Director of the Scientific, Clinical and Educational Center "Cardiology" of the Institute of High Medical Technologies, Faculty of Medicine,

nikita_perepech@mail.ruhttps://orcid.org/0000-0002-0139-5177СитниковаМ. Ю.SitnikovaM. Yu.

руководитель научно-исследовательского отдела сердечной недостаточности

drsitnikova@mail.ruСкворцовА. А.SkvortsovA. A.

ведущий научный сотрудник

Head of the Research Department of Heart Failure

skvortsov00@yandex.ruСкибицкийВ. В.SkibitskiyV. V.

заведующий кафедрой госпитальной терапии

Head of the Department of Hospital Therapy

vvsdoctor@mail.ruhttps://orcid.org/0000-0002-9323-592XЧесниковаА. И.ChesnikovaA. I.

профессор кафедры внутренних бо-лезней №1

rostov-ossn@yandex.ru«Медицинский научно образовательный центр МГУ имени М. В. Ломоносова», Москва, Россия МГУ имени М. В. Ломоносова, Факультет фундаментальной медицины, Москва, РоссияРоссияMedical Research and Educational Center of the M. V. Lomonosov Moscow State University, Moscow, Russia Faculty of Fundamental Medicine, Lomonosov Moscow State University, RussiaRussian FederationНаучно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук, Томск, РоссияРоссия"Research Institute for Cardiology", Siberian State Medical University, Tomsk National Research Medical Center, Russian Academy of SciencesRussian FederationФГБУ «НМИЦ кардиологии» Минздрава РФ, Москва, РоссияРоссияScientific Medical Research Center of Cardiology, RussiaRussian FederationФГБОУ ВО «РНИМУ имени Н.И. Пирогова» Минздрава РФ, Москва, РоссияРоссияRussian National Research Medical University named after Pirogov, MoscowRussian FederationФГАОУ ВО «Первый МГМУ имени И.М. Сеченова» Минздрава РФ (Сеченовский университет), Москва, РоссияРоссияSechenov Moscow State Medical University, Moscow, RussiaRussian FederationФГБОУ ВО «МГМСУ имени А.И. Евдокимова» Минздрава РФ, Москва, РоссияРоссияMoscow State Medical and Dental University named after Evdokimov, Moscow, RussiaRussian FederationФГБОУ ВО «Казанский ГМУ» Минздрава РФ, Казань, РоссияРоссияKazan State Medical University, Kazan, RussiaRussian FederationГБОУ ДПО «РМАПО» Минздрава РФ, Москва, РоссияРоссияRussian Medical Academy of Postgraduate Education, Moscow, RussiaRussian FederationФГБУ «НМИЦ ПМ» Минздрава РФ, Москва, РоссияРоссияNational Medical Research Centre for Therapy and Preventive Medicine, Moscow, RussiaRussian FederationГБУЗ «СОККД», Самара, РоссияРоссияSamara Regional Clinical Cardiological Dispensary, RussiaRussian FederationФГАОУ ВО «РУДН», Москва, РоссияРоссияRussian State University of Peoples' Friendship, Moscow, RussiaRussian FederationФГБОУ ВО «ПГМУ имени академика Е.А. Вагнера» Минздрава РФ, Пермь, РоссияРоссияFederal State Budgetary Institution of Healthcare of Higher Education “Perm State Medical University named after Academician E.A. Wagner ", RussiaRussian FederationНаучно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук, Томск, РоссияРоссия"Research Institute for Cardiology", Siberian State Medical University, Tomsk National Research Medical Center, Russian Academy of Sciences, RussiaRussian FederationФГБУ «НМИЦ ПМ» Минздрава РФ, Москва, Россия «Робертсоновский центр биостатистики», Университет Глазго, ВеликобританияРоссияNational Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia Robertson Centre for Biostatistics, Glasgow, Great BritainRussian FederationФГБОУ ВО «Санкт-Петербургский государственный университет», Санкт-Петербург, РоссияРоссияSt. Petersburg State University, RussiaRussian Federation«НМИЦ им. В.А. Алмазова» Минздрава РФ, Санкт-Петербург, РоссияРоссияAlmazov National Medical Research Center, St. Petersburg, RussiaRussian FederationФГБОУ ВО «КубГМУ» Минздрава РФ, Краснодар, РоссияРоссияKuban State Medical University" of the Ministry of Health of the Russian Federation, RussiaRussian FederationФГБОУ ВО «РостГМУ» Минздрава РФ, Ростов-на-Дону, РоссияРоссияRostov State Medical University, RussiaRussian Federation20203112202060121347Copyright © Kardiomag, 20202020KardiomagKardiomaghttps://cardio.elpub.ru/jour/about/submissions#copyrightNoticehttps://cardio.elpub.ru/jour/article/view/1427

В документе рассматриваются ключевые вопросы диуретической терапии при ХСН с позиции современных представлений о патогенезе отечного синдрома, его диагностика, а также особенности применения диуретиков в различных клинических ситуациях.

The document focuses on key issues of diuretic therapy in CHF from the standpoint of current views on the pathogenesis of edema syndrome, its diagnosis, and characteristics of using diuretics in various clinical situations.

ДиуретикиХСНзадержка жидкостиотекидекомпенсацияводно-солевой режимэуволемияDiureticsCHFfluid retentionedemadecompensationsalt-water regimeneuvolemiaКонфликт интересов не заявлен.No conflict of interest is reported.ReferencesМареев В.Ю., Фомин И.В., Агеев Ф.Т., Беграмбекова Ю.Л., Васюк Ю.А., Гарганеева А.А. и др. Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология. 2018;58 (6S): 8-158. DOI: 10.18087/cardio.2475Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A. et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58 (6S): 8-158. DOI: 10.18087/cardio.2475Lopez-Sendon J. The heart failure epidemic. Medicographia. 2011;33 (4):363-9. [Av. at: https://www.medicographia.com/2012/02/theheart-failure-epidemic/]Lopez-Sendon J. The heart failure epidemic. Medicographia. 2011;33 (4):363-9. [Av. at: https://www.medicographia.com/2012/02/theheart-failure-epidemic/]Longjian Liu, Howard J. Eisen. Epidemiology of Heart Failure and Scope of the Problem. Cardiology Clinics. 2014;32 (1):1-8. DOI: 10.1016/j.ccl.2013.09.009Longjian Liu, Howard J. Eisen. Epidemiology of Heart Failure and Scope of the Problem. Cardiology Clinics. 2014;32 (1):1-8. DOI: 10.1016/j.ccl.2013.09.009Störk S, Handrock R, Jacob J, Walker J, Calado F, Lahoz R et al. Epidemiology of heart failure in Germany: a retrospective database study. Clinical Research in Cardiology. 2017;106 (11):913-22. DOI: 10.1007/s00392-017-1137-7Störk S, Handrock R, Jacob J, Walker J, Calado F, Lahoz R et al. Epidemiology of heart failure in Germany: a retrospective database study. Clinical Research in Cardiology. 2017;106 (11):913-22. DOI: 10.1007/s00392-017-1137-7Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93 (9):1137-46. DOI: 10.1136/hrt.2003.025270Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93 (9):1137-46. DOI: 10.1136/hrt.2003.025270Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т., Фомин И.В., Бадин Ю.В., Поляков Д.С. и др. Истинная распространенность ХСН в Европейской части Российской Федерации (ЭПОХА, госпитальный этап) Журнал Сердечная Недостаточность. 2011;12 (2):63-8Belenkov Yu.N., Mareev V.Yu., Ageev F.T., Fomin I.V., Badin Yu.V., Polyakov D. S. et al. Veritable prevalence of CHF in the European part of Russian Federation (EPOCHA trial, hospital stage). Russian Heart Failure Journal. 2011;12 (2):63-8.Министерство Здравоохранения Российской Федерации. Хроническая сердечная недостаточность. Клинические рекомендации. КР 156/1. 2020. Доступно на: http://cr.rosminzdrav.ru/#!/schema/134Ministry of Health of Russian Federation. Chronic heart failure. clinical recommendations. KR 156/1. Av. at: http://cr.rosminzdrav.ru/#!/schema/134. 2020.Cleland JG, Swedberg K, Cohen-Solal A, Cosin-Aguilar J, Dietz R, Follath F et al. The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. European Journal of Heart Failure. 2000;2 (2):123-32. DOI: 10.1016/s1388-9842 (00) 00081-7Cleland JG, Swedberg K, Cohen-Solal A, Cosin-Aguilar J, Dietz R, Follath F et al. The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. European Journal of Heart Failure. 2000;2 (2):123-32. DOI: 10.1016/s1388-9842 (00) 00081-7Гарганеева А.А., Кужелева Е.А., Кузьмичкина М.А., Рябов В. В., Мареев Ю. В., Мареев В.Ю. Изменения характеристик и лечения больных с хронической сердечной недостаточностью, поступивших в кардиологический стационар в 2002 и 2016 годах. Кардиология. 2018;58 (12S): 18-26. DOI: 10.18087/cardio.2605Garganeeva A.A., Kuzheleva E.A., Kuzmichkina M.A., Ryabov V.V., Mareev Yu.V., Mareev V. Yu. Characteristics and treatment of patients with heart failure admitted to a cardiology department in 2002 and 2016. Kardiologiia. 2018;58 (12S): 18-26. DOI: 10.18087/cardio.2605Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. European Journal of Heart Failure. 2016;18 (6):613-25. DOI: 10.1002/ejhf.566Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. European Journal of Heart Failure. 2016;18 (6):613-25. DOI: 10.1002/ejhf.566Арутюнов А.Г., Драгунов Д.О., Арутюнов Г.П., Рылова А.К., Пашкевич Д.Д., Витер К.В. и др. Первое открытое исследование синдрома острой декомпенсации сердечной недостаточности и сопутствующих заболеваний в Российской Федерации. Независимый регистр ОРАКУЛ-РФ. Кардиология. 2015;55 (5):12-21Arutyunov A.G., Dragunov D.O., Arutyunov G.P., Rylova A.K., Pashkevich D.D., Viter K.V. et al. First open study of syndrome of acute decompensation of heart failure and concomitant diseases in Russian Federation: independent registry ORAKUL. Kardiologiia. 2015;55 (5):12-21.Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. European Heart Journal. 2003;24 (5):442-63. DOI: 10.1016/s0195-668x (02) 00823-0Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. European Heart Journal. 2003;24 (5):442-63. DOI: 10.1016/s0195-668x (02) 00823-0Gheorghiade M, Pang PS. Acute Heart Failure Syndromes. Journal of the American College of Cardiology. 2009;53 (7):557-73. DOI: 10.1016/j.jacc.2008.10.041Gheorghiade M, Pang PS. Acute Heart Failure Syndromes. Journal of the American College of Cardiology. 2009;53 (7):557-73. DOI: 10.1016/j.jacc.2008.10.041Орлова Я.А., Ткачева О.Н., Арутюнов Г.П., Котовская Ю.В., Лопатин Ю.М., Мареев В.Ю. и др. Особенности диагностики и лечения хронической сердечной недостаточности у пациентов пожилого и старческого возраста. Мнение экспертов Общества специалистов по сердечной недостаточности, Российской ассоциации геронтологов и гериатров и евразийской ассоциации терапевтов. Кардиология. 2018;58 (12S): 42-72. DOI: 10.18087/cardio.2560Orlova Ya.A., Tkacheva O.N., Arutyunov G.P., Kotovskaya Yu.V., Lopatin Yu.M., Mareev V.Yu. et al. Features of diagnostics and treatment of chronic heart failure in elderly and senile patients. Expert opinion of the Society of Experts in Heart Failure, Russian Association of Gerontologists, and Euroasian Association of Therapists. Kardiologiia. 2018;58 (12S): 42-72. DOI: 10.18087/cardio.2560Гиляревский С.Р., Голшмид М.В., Кузьмина И.М., Бенделиани Н.Г. Анемия у больных с хронической сердечной недостаточностью: современное состояние проблемы. Журнал им.Н.В. Склифосовского «Неотложная медицинская помощь». 2019;8 (1):68-73. DOI: 10.23934/2223-9022-2019-8-1-68-73Gilyarevsky S.R., Golshmid M.V., Kuzmina I.M., Bendeliani N.G. Anemia in Patients with Heart Failure: Current State of the Problem. Russian Sklifosovsky Journal ‘Emergency Medical Care’. 2019;8 (1):68-73. DOI: 10.23934/2223-9022-2019-8-1-68-73Колегова И.И., Чернявина А.И., Козиолова Н.А. Характеристика течения хронической сердечной недостаточности и состояния органов-мишеней у больных кардиоренальным синдромом. Российский кардиологический журнал. 2018;23 (1):21-6. DOI: 10.15829/1560-4071-2018-1-21-26Kolegova I.I., Chernyavina A.I., Koziolova N.A. Characteristics of the chronic heart failure course and target organ condition in cardiorenal syndrome. Russian Journal of Cardiology. 2018;23 (1):21-6. DOI: 10.15829/1560-4071-2018-1-21-26Тарловская Е.И., Михайлова Ю.В. Хроническая сердечная недостаточность и частота приема нестероидных противовоспалительных средств: возможные риски по данным локального регистра. Российский кардиологический журнал. 2020;25 (1):59-64. DOI: 10.15829/1560-4071-2020-1-3677Tarlovskaya E.I., Mikhailova Yu.V. Chronic heart failure and the frequency of taking nonsteroidal anti-inflammatory drugs: a register-based study on the possible risks. Russian Journal of Cardiology. 2020;25 (1):59-64.Fudim M, O’Connor CM, Mulder H, Coles A, Bhatt AS, Ambrosy AP et al. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION. American Heart Journal. 2018;205:133- 41. DOI: 10.1016/j.ahj.2018.06.017Fudim M, O’Connor CM, Mulder H, Coles A, Bhatt AS, Ambrosy AP et al. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION. American Heart Journal. 2018;205:133- 41. DOI: 10.1016/j.ahj.2018.06.017Dini FL, Ghio S, Klersy C, Rossi A, Simioniuc A, Scelsi L et al. Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. International Journal of Clinical Practice. 2013;67 (7):656-64. DOI: 10.1111/ijcp.12144Dini FL, Ghio S, Klersy C, Rossi A, Simioniuc A, Scelsi L et al. Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. International Journal of Clinical Practice. 2013;67 (7):656-64. DOI: 10.1111/ijcp.12144Abdel-Qadir HM, Tu JV, Yun L, Austin PC, Newton GE, Lee DS. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. American Heart Journal. 2010;160 (2):264- 271.e1. DOI: 10.1016/j.ahj.2010.05.032Abdel-Qadir HM, Tu JV, Yun L, Austin PC, Newton GE, Lee DS. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. American Heart Journal. 2010;160 (2):264- 271.e1. DOI: 10.1016/j.ahj.2010.05.032Devroey D, Van Casteren V. Symptoms and clinical signs associated with hospital admission and mortality for heart failure. Central European Journal of Public Health. 2010;18 (4):209-14. PMID: 21361105Devroey D, Van Casteren V. Symptoms and clinical signs associated with hospital admission and mortality for heart failure. Central European Journal of Public Health. 2010;18 (4):209-14. PMID: 21361105DeVore AD, Hasselblad V, Mentz RJ, O’Connor CM, Armstrong PW, McMurray JJ et al. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF: Diuretics in ASCEND-HF. European Journal of Heart Failure. 2015;17 (3):340-6. DOI: 10.1002/ejhf.235DeVore AD, Hasselblad V, Mentz RJ, O’Connor CM, Armstrong PW, McMurray JJ et al. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF: Diuretics in ASCEND-HF. European Journal of Heart Failure. 2015;17 (3):340-6. DOI: 10.1002/ejhf.235Kiernan MS, Stevens SR, Tang WHW, Butler J, Anstrom KJ, Birati EY et al. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials. Journal of Cardiac Failure. 2018;24 (7):428-38. DOI: 10.1016/j.cardfail.2018.02.002Kiernan MS, Stevens SR, Tang WHW, Butler J, Anstrom KJ, Birati EY et al. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials. Journal of Cardiac Failure. 2018;24 (7):428-38. DOI: 10.1016/j.cardfail.2018.02.002Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ. Diuretics for heart failure. Cochrane Database of Systematic Reviews. 2012;2: CD003838. DOI: 10.1002/14651858. CD003838.pub3Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ. Diuretics for heart failure. Cochrane Database of Systematic Reviews. 2012;2: CD003838. DOI: 10.1002/14651858. CD003838.pub3Drechsler K, Dietz R, Klein H, Wollert KC, Storp D, Molling J et al. Euro heart failure survey: Medical treatment not in line with current guidelines. Zeitschrift für Kardiologie. 2005;94 (8):510-5. DOI: 10.1007/s00392-005-0245-yDrechsler K, Dietz R, Klein H, Wollert KC, Storp D, Molling J et al. Euro heart failure survey: Medical treatment not in line with current guidelines. Zeitschrift für Kardiologie. 2005;94 (8):510-5. DOI: 10.1007/s00392-005-0245-yКостенко В.А., Ситникова М.Ю. Скородумова Е.А., Федоров А.Н., Скородумова Е.Г. Новая шкала оценки двухлетнего прогноза выживаемости для пациентов, госпитализированных в многопрофильный стационар по поводу острой декомпенсированной сердечной недостаточности. Кардиология. 2017:57 (6):33-9Kostenko V.A., Sitnikova M.Yu., Skorodumova E.A., Fedorov A.N., Skorodumova E.G. New Scale for Assessment of Prognosis of Survival for Two Years After Hospitalization Because of Acute Decompensation of Heart Failure. Kardiologiia. 2017;57 (6):33-9.Mullens W, Damman K, Harjola V-P, Mebazaa A, Brunner-La Rocca H-P, Martens P et al. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2019;21 (2):137-55. DOI: 10.1002/ejhf.1369Mullens W, Damman K, Harjola V-P, Mebazaa A, Brunner-La Rocca H-P, Martens P et al. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2019;21 (2):137-55. DOI: 10.1002/ejhf.1369Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62 (16):e147-239. DOI: 10.1016/j.jacc.2013.05.019Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62 (16):e147-239. DOI: 10.1016/j.jacc.2013.05.019Schrier RW. Body Fluid Volume Regulation in Health and Disease: A Unifying Hypothesis. Annals of Internal Medicine. 1990;113 (2):155-9. DOI: 10.7326/0003-4819-113-2-155Schrier RW. Body Fluid Volume Regulation in Health and Disease: A Unifying Hypothesis. Annals of Internal Medicine. 1990;113 (2):155-9. DOI: 10.7326/0003-4819-113-2-155Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal Syndrome. Journal of the American College of Cardiology. 2008;52 (19):1527-39. DOI: 10.1016/j.jacc.2008.07.051Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal Syndrome. Journal of the American College of Cardiology. 2008;52 (19):1527-39. DOI: 10.1016/j.jacc.2008.07.051Bekheirnia M, Schrier R. Pathophysiology of water and sodium retention: edematous states with normal kidney function. Current Opinion in Pharmacology. 2006;6 (2):202-7. DOI: 10.1016/j. coph.2005.09.008Bekheirnia M, Schrier R. Pathophysiology of water and sodium retention: edematous states with normal kidney function. Current Opinion in Pharmacology. 2006;6 (2):202-7. DOI: 10.1016/j. coph.2005.09.008Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WHW et al. Abdominal Contributions to Cardiorenal Dysfunction in Congestive Heart Failure. Journal of the American College of Cardiology. 2013;62 (6):485-95. DOI: 10.1016/j.jacc.2013.04.070Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WHW et al. Abdominal Contributions to Cardiorenal Dysfunction in Congestive Heart Failure. Journal of the American College of Cardiology. 2013;62 (6):485-95. DOI: 10.1016/j.jacc.2013.04.070Miller WL. Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed. Circulation: Heart Failure. 2016;9 (8):e002922. DOI: 10.1161/CIRCHEARTFAILURE.115.002922Miller WL. Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed. Circulation: Heart Failure. 2016;9 (8):e002922. DOI: 10.1161/CIRCHEARTFAILURE.115.002922Burnett JC, Opgenorth TJ, Granger JP. The renal action of atrial natriuretic peptide during control of glomerular filtration. Kidney International. 1986;30 (1):16-9. DOI: 10.1038/ki.1986.144Burnett JC, Opgenorth TJ, Granger JP. The renal action of atrial natriuretic peptide during control of glomerular filtration. Kidney International. 1986;30 (1):16-9. DOI: 10.1038/ki.1986.144Richards AM. The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides. Heart (British Cardiac Society). 1996;76 (3 Suppl 3):36-44. DOI: 10.1136/hrt.76.3_suppl_3.36Richards AM. The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides. Heart (British Cardiac Society). 1996;76 (3 Suppl 3):36-44. DOI: 10.1136/hrt.76.3_suppl_3.36Melo LG, Veress AT, Ackermann U, Sonnenberg H. Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors. American Journal of Physiology-Heart and Circulatory Physiology. 1998;275 (5):H1826-33. DOI: 10.1152/ajpheart.1998.275.5. H1826Melo LG, Veress AT, Ackermann U, Sonnenberg H. Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors. American Journal of Physiology-Heart and Circulatory Physiology. 1998;275 (5):H1826-33. DOI: 10.1152/ajpheart.1998.275.5. H1826Komajda M, Lam CSP. Heart failure with preserved ejection fraction: a clinical dilemma. European Heart Journal. 2014;35 (16):1022-32. DOI: 10.1093/eurheartj/ehu067Komajda M, Lam CSP. Heart failure with preserved ejection fraction: a clinical dilemma. European Heart Journal. 2014;35 (16):1022-32. DOI: 10.1093/eurheartj/ehu067Greene SJ, Gheorghiade M, Borlaug BA, Pieske B, Vaduganathan M, Burnett JC et al. The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction. Journal of the American Heart Association. 2013;2 (6):e000536. DOI: 10.1161/JAHA.113.000536Greene SJ, Gheorghiade M, Borlaug BA, Pieske B, Vaduganathan M, Burnett JC et al. The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction. Journal of the American Heart Association. 2013;2 (6):e000536. DOI: 10.1161/JAHA.113.000536Schrier RW, Abraham WT. Hormones and Hemodynamics in Heart Failure. New England Journal of Medicine. 1999;341 (8):577-85. DOI: 10.1056/NEJM199908193410806Schrier RW, Abraham WT. Hormones and Hemodynamics in Heart Failure. New England Journal of Medicine. 1999;341 (8):577-85. DOI: 10.1056/NEJM199908193410806Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. American Journal of Physiology-Heart and Circulatory Physiology. 2006;290 (1):H17-29. DOI: 10.1152/ajpheart.00684.2005Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. American Journal of Physiology-Heart and Circulatory Physiology. 2006;290 (1):H17-29. DOI: 10.1152/ajpheart.00684.2005Volpe M, Carnovali M, Mastromarino V. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clinical Science. 2015;130 (2):57-77. DOI: 10.1042/CS20150469Volpe M, Carnovali M, Mastromarino V. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clinical Science. 2015;130 (2):57-77. DOI: 10.1042/CS20150469Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in Acute Heart Failure Syndromes: An Essential Target of Evaluation and Treatment. The American Journal of Medicine. 2006;119 (12):S3-10. DOI: 10.1016/j.amjmed.2006.09.011Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in Acute Heart Failure Syndromes: An Essential Target of Evaluation and Treatment. The American Journal of Medicine. 2006;119 (12):S3-10. DOI: 10.1016/j.amjmed.2006.09.011Zile MR, Bennett TD, St. John Sutton M, Cho YK, Adamson PB, Aaron MF et al. Transition from Chronic Compensated to Acute Decompensated Heart Failure: Pathophysiological Insights Obtained from Continuous Monitoring of Intracardiac Pressures. Circulation. 2008;118 (14):1433-41. DOI: 10.1161/CIRCULATIONAHA.108.783910Zile MR, Bennett TD, St. John Sutton M, Cho YK, Adamson PB, Aaron MF et al. Transition from Chronic Compensated to Acute Decompensated Heart Failure: Pathophysiological Insights Obtained from Continuous Monitoring of Intracardiac Pressures. Circulation. 2008;118 (14):1433-41. DOI: 10.1161/CIRCULATIONAHA.108.783910Adamson PB. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices. Current Heart Failure Reports. 2009;6 (4):287-92. DOI: 10.1007/s11897-009-0039-zAdamson PB. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices. Current Heart Failure Reports. 2009;6 (4):287-92. DOI: 10.1007/s11897-009-0039-zNijst P, Verbrugge FH, Grieten L, Dupont M, Steels P, Tang WHW et al. The Pathophysiological Role of Interstitial Sodium in Heart Failure. Journal of the American College of Cardiology. 2015;65 (4):378- 88. DOI: 10.1016/j.jacc.2014.11.025Nijst P, Verbrugge FH, Grieten L, Dupont M, Steels P, Tang WHW et al. The Pathophysiological Role of Interstitial Sodium in Heart Failure. Journal of the American College of Cardiology. 2015;65 (4):378- 88. DOI: 10.1016/j.jacc.2014.11.025Gelman S, Warner DS, Warner MA. Venous Function and Central Venous Pressure: a physiologic story. Anesthesiology. 2008;108 (4):735-48. DOI: 10.1097/ALN.0b013e3181672607Gelman S, Warner DS, Warner MA. Venous Function and Central Venous Pressure: a physiologic story. Anesthesiology. 2008;108 (4):735-48. DOI: 10.1097/ALN.0b013e3181672607Greenway CV. Role of splanchnic venous system in overall cardiovascular homeostasis. Federation Proceedings. 1983;42 (6):1678-84. PMID: 6832386Greenway CV. Role of splanchnic venous system in overall cardiovascular homeostasis. Federation Proceedings. 1983;42 (6):1678-84. PMID: 6832386Yu C-M, Wang L, Chau E, Chan RH-W, Kong S-L, Tang M-O et al. Intrathoracic Impedance Monitoring in Patients with Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization. Circulation. 2005;112 (6):841-8. DOI: 10.1161/CIRCULATIONAHA.104.492207Yu C-M, Wang L, Chau E, Chan RH-W, Kong S-L, Tang M-O et al. Intrathoracic Impedance Monitoring in Patients with Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization. Circulation. 2005;112 (6):841-8. DOI: 10.1161/CIRCULATIONAHA.104.492207Miller WL, Mullan BP. Understanding the Heterogeneity in Volume Overload and Fluid Distribution in Decompensated Heart Failure Is Key to Optimal Volume Management: role for blood volume quantitation. JACC: Heart Failure. 2014;2 (3):298-305. DOI: 10.1016/j.jchf.2014.02.007Miller WL, Mullan BP. Understanding the Heterogeneity in Volume Overload and Fluid Distribution in Decompensated Heart Failure Is Key to Optimal Volume Management: role for blood volume quantitation. JACC: Heart Failure. 2014;2 (3):298-305. DOI: 10.1016/j.jchf.2014.02.007Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of Weight Change Preceding Hospitalization for Heart Failure. Circulation. 2007;116 (14):1549-54. DOI: 10.1161/CIRCULATIONAHA.107.690768Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of Weight Change Preceding Hospitalization for Heart Failure. Circulation. 2007;116 (14):1549-54. DOI: 10.1161/CIRCULATIONAHA.107.690768Dovancescu S, Pellicori P, Mabote T, Torabi A, Clark AL, Cleland JGF. The effects of short-term omission of daily medication on the pathophysiology of heart failure: Medication omission in heart failure. European Journal of Heart Failure. 2017;19 (5):643-9. DOI: 10.1002/ejhf.748Dovancescu S, Pellicori P, Mabote T, Torabi A, Clark AL, Cleland JGF. The effects of short-term omission of daily medication on the pathophysiology of heart failure: Medication omission in heart failure. European Journal of Heart Failure. 2017;19 (5):643-9. DOI: 10.1002/ejhf.748Fallick C, Sobotka PA, Dunlap ME. Sympathetically Mediated Changes in Capacitance: Redistribution of the Venous Reservoir as a Cause of Decompensation. Circulation: Heart Failure. 2011;4 (5):669-75. DOI: 10.1161/CIRCHEARTFAILURE.111.961789Fallick C, Sobotka PA, Dunlap ME. Sympathetically Mediated Changes in Capacitance: Redistribution of the Venous Reservoir as a Cause of Decompensation. Circulation: Heart Failure. 2011;4 (5):669-75. DOI: 10.1161/CIRCHEARTFAILURE.111.961789Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure. 2016;18 (8):891-975. DOI: 10.1002/ejhf.592Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure. 2016;18 (8):891-975. DOI: 10.1002/ejhf.592Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. The New England Journal of Medicine. 2001;345 (8):574-81. DOI: 10.1056/NEJMoa010641Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. The New England Journal of Medicine. 2001;345 (8):574-81. DOI: 10.1056/NEJMoa010641Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JEA, Cleland JG et al. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. European Journal of Heart Failure. 2010;12 (5):423-33. DOI: 10.1093/eurjhf/hfq045Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JEA, Cleland JG et al. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. European Journal of Heart Failure. 2010;12 (5):423-33. DOI: 10.1093/eurjhf/hfq045Martens P, Mullens W. How to tackle congestion in acute heart failure. The Korean Journal of Internal Medicine. 2018;33 (3):462-73. DOI: 10.3904/kjim.2017.355Martens P, Mullens W. How to tackle congestion in acute heart failure. The Korean Journal of Internal Medicine. 2018;33 (3):462-73. DOI: 10.3904/kjim.2017.355Cohn JN. Jugular venous pressure monitoring: A lost art? Journal of Cardiac Failure. 1997;3 (2):71-3. DOI: 10.1016/S1071-9164 (97) 90037-3Cohn JN. Jugular venous pressure monitoring: A lost art? Journal of Cardiac Failure. 1997;3 (2):71-3. DOI: 10.1016/S1071-9164 (97) 90037-3Vinayak AG, Levitt J, Gehlbach B, Pohlman AS, Hall JB, Kress JP. Usefulness of the External Jugular Vein Examination in Detecting Abnormal Central Venous Pressure in Critically Ill Patients. Archives of Internal Medicine. 2006;166 (19):2132-7. DOI: 10.1001/ archinte.166.19.2132Vinayak AG, Levitt J, Gehlbach B, Pohlman AS, Hall JB, Kress JP. Usefulness of the External Jugular Vein Examination in Detecting Abnormal Central Venous Pressure in Critically Ill Patients. Archives of Internal Medicine. 2006;166 (19):2132-7. DOI: 10.1001/ archinte.166.19.2132Chakko S, Woska D, Martinez H, de Marchena E, Futterman L, Kessler KM et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. The American Journal of Medicine. 1991;90 (3):353-9. DOI: 10.1016/0002-9343 (91) 80016-fChakko S, Woska D, Martinez H, de Marchena E, Futterman L, Kessler KM et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. The American Journal of Medicine. 1991;90 (3):353-9. DOI: 10.1016/0002-9343 (91) 80016-fCampbell P, Drazner MH, Kato M, Lakdawala N, Palardy M, Nohria A et al. Mismatch of Right- and Left-Sided Filling Pressures in Chronic Heart Failure. Journal of Cardiac Failure. 2011;17 (7):561-8. DOI: 10.1016/j.cardfail.2011.02.013Campbell P, Drazner MH, Kato M, Lakdawala N, Palardy M, Nohria A et al. Mismatch of Right- and Left-Sided Filling Pressures in Chronic Heart Failure. Journal of Cardiac Failure. 2011;17 (7):561-8. DOI: 10.1016/j.cardfail.2011.02.013McGee SR. Physical examination of venous pressure: a critical review. American Heart Journal. 1998;136 (1):10-8. DOI: 10.1016/s0002- 8703 (98) 70175-9McGee SR. Physical examination of venous pressure: a critical review. American Heart Journal. 1998;136 (1):10-8. DOI: 10.1016/s0002- 8703 (98) 70175-9Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. Journal of the American College of Cardiology. 1993;22 (4):968-74. DOI: 10.1016/0735-1097(93)90405-PButman SM, Ewy GA, Standen JR, Kern KB, Hahn E. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. Journal of the American College of Cardiology. 1993;22 (4):968-74. DOI: 10.1016/0735-1097(93)90405-PThibodeau JT, Drazner MH. The Role of the Clinical Examination in Patients with Heart Failure. JACC: Heart Failure. 2018;6 (7):543- 51. DOI: 10.1016/j.jchf.2018.04.005Thibodeau JT, Drazner MH. The Role of the Clinical Examination in Patients with Heart Failure. JACC: Heart Failure. 2018;6 (7):543- 51. DOI: 10.1016/j.jchf.2018.04.005Sochowski RA, Dubbin JD, Naqvi SZ. Clinical and hemodynamic assessment of the hepatojugular reflux. The American Journal of Cardiology. 1990;66 (12):1002-6. DOI: 10.1016/0002-9149(90)90940-3Sochowski RA, Dubbin JD, Naqvi SZ. Clinical and hemodynamic assessment of the hepatojugular reflux. The American Journal of Cardiology. 1990;66 (12):1002-6. DOI: 10.1016/0002-9149(90)90940-3Wiese J. The abdominojugular reflux sign. The American Journal of Medicine. 2000;109 (1):59-61. DOI: 10.1016/S0002-9343 (00) 00443-5Wiese J. The abdominojugular reflux sign. The American Journal of Medicine. 2000;109 (1):59-61. DOI: 10.1016/S0002-9343 (00) 00443-5Ewy GA. The Abdominojugular Test: Technique and Hemodynamic Correlates. Annals of Internal Medicine. 1988;109 (6):456-60. DOI: 10.7326/0003-4819-109-6-456Ewy GA. The Abdominojugular Test: Technique and Hemodynamic Correlates. Annals of Internal Medicine. 1988;109 (6):456-60. DOI: 10.7326/0003-4819-109-6-456Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS. Pathophysiologic targets in the early phase of acute heart failure syndromes. The American Journal of Cardiology. 2005;96 (6A): 11G-17G. DOI: 10.1016/j.amjcard.2005.07.016Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS. Pathophysiologic targets in the early phase of acute heart failure syndromes. The American Journal of Cardiology. 2005;96 (6A): 11G-17G. DOI: 10.1016/j.amjcard.2005.07.016Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF et al. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights from Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circulation: Heart Failure. 2015;8 (4):741-8. DOI: 10.1161/CIRCHEARTFAILURE.114.001957Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF et al. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights from Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circulation: Heart Failure. 2015;8 (4):741-8. DOI: 10.1161/CIRCHEARTFAILURE.114.001957Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. Journal of the American College of Cardiology. 2003;41 (10):1797-804. DOI: 10.1016/ S0735-1097(03)00309-7Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. Journal of the American College of Cardiology. 2003;41 (10):1797-804. DOI: 10.1016/S0735-1097(03)00309-7Formiga F, Chivite D, Manito N, Casas S, Llopis F, Pujol R. Hospitalization due to acute heart failure. Role of the precipitating factors. International Journal of Cardiology. 2007;120 (2):237-41. DOI: 10.1016/j.ijcard.2006.10.004Formiga F, Chivite D, Manito N, Casas S, Llopis F, Pujol R. Hospitalization due to acute heart failure. Role of the precipitating factors. International Journal of Cardiology. 2007;120 (2):237-41. DOI: 10.1016/j.ijcard.2006.10.004Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. European Heart Journal. 2005;27 (10):1207-15. DOI: 10.1093/eurheartj/ehi845Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. European Heart Journal. 2005;27 (10):1207-15. DOI: 10.1093/eurheartj/ehi845Girerd N, Seronde M-F, Coiro S, Chouihed T, Bilbault P, Braun F et al. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. JACC: Heart Failure. 2018;6 (4):273-85. DOI: 10.1016/j.jchf.2017.09.023Girerd N, Seronde M-F, Coiro S, Chouihed T, Bilbault P, Braun F et al. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. JACC: Heart Failure. 2018;6 (4):273-85. DOI: 10.1016/j.jchf.2017.09.023Van der Meer P, Postmus D, Ponikowski P, Cleland JG, O’Connor CM, Cotter G et al. The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting with Acute Decompensated Heart Failure. Journal of the American College of Cardiology. 2013;61 (19):1973-81. DOI: 10.1016/j.jacc.2012.12.050Van der Meer P, Postmus D, Ponikowski P, Cleland JG, O’Connor CM, Cotter G et al. The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting with Acute Decompensated Heart Failure. Journal of the American College of Cardiology. 2013;61 (19):1973-81. DOI: 10.1016/j.jacc.2012.12.050Mentz RJ, Kjeldsen K, Rossi GP, Voors AA, Cleland JGF, Anker SD et al. Decongestion in acute heart failure. European Journal of Heart Failure. 2014;16 (5):471-82. DOI: 10.1002/ejhf.74Mentz RJ, Kjeldsen K, Rossi GP, Voors AA, Cleland JGF, Anker SD et al. Decongestion in acute heart failure. European Journal of Heart Failure. 2014;16 (5):471-82. DOI: 10.1002/ejhf.74Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. The New England Journal of Medicine. 2002;347 (3):161-7. DOI: 10.1056/NEJMoa020233Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. The New England Journal of Medicine. 2002;347 (3):161-7. DOI: 10.1056/NEJMoa020233Januzzi JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. The American Journal of Cardiology. 2005;95 (8):948-54. DOI: 10.1016/j.amjcard.2004.12.032Januzzi JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. The American Journal of Cardiology. 2005;95 (8):948-54. DOI: 10.1016/j.amjcard.2004.12.032Januzzi JL, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD et al. N-Terminal Pro - B-Type Natriuretic Peptide in the Emergency Department. Journal of the American College of Cardiology. 2018;71 (11):1191-200. DOI: 10.1016/j.jacc.2018.01.021Januzzi JL, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD et al. N-Terminal Pro - B-Type Natriuretic Peptide in the Emergency Department. Journal of the American College of Cardiology. 2018;71 (11):1191-200. DOI: 10.1016/j.jacc.2018.01.021Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. European Journal of Heart Failure. 2019;21 (6):715-31. DOI: 10.1002/ejhf.1494Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. European Journal of Heart Failure. 2019;21 (6):715-31. DOI: 10.1002/ejhf.1494Maisel A, Mueller C, Adams K, Anker SD, Aspromonte N, Cleland JGF et al. State of the art: Using natriuretic peptide levels in clinical practice. European Journal of Heart Failure. 2008;10 (9):824-39. DOI: 10.1016/j.ejheart.2008.07.014Maisel A, Mueller C, Adams K, Anker SD, Aspromonte N, Cleland JGF et al. State of the art: Using natriuretic peptide levels in clinical practice. European Journal of Heart Failure. 2008;10 (9):824-39. DOI: 10.1016/j.ejheart.2008.07.014Brenden CK, Hollander JE, Guss D, McCullough PA, Nowak R, Green G et al. Gray zone BNP levels in heart failure patients in the emergency department: Results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study. American Heart Journal. 2006;151 (5):1006-11. DOI: 10.1016/j.ahj.2005.10.017Brenden CK, Hollander JE, Guss D, McCullough PA, Nowak R, Green G et al. Gray zone BNP levels in heart failure patients in the emergency department: Results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study. American Heart Journal. 2006;151 (5):1006-11. DOI: 10.1016/j.ahj.2005.10.017Januzzi JL, van Kimmenade R, Lainchbury J, Bayés-Genis A, Ordoñez-llanos J, Santaló-Bel M et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study. European Heart Journal. 2005;27 (3):330-7. DOI: 10.1093/eurheartj/ehi631Januzzi JL, van Kimmenade R, Lainchbury J, Bayés-Genis A, Ordoñez-llanos J, Santaló-Bel M et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study. European Heart Journal. 2005;27 (3):330-7. DOI: 10.1093/eurheartj/ehi631Araújo JP, Azevedo A, Lourenço P, Rocha-Gonçalves F, Ferreira A, Bettencourt P. Intraindividual Variation of Amino-Terminal Pro-BType Natriuretic Peptide Levels in Patients with Stable Heart Failure. The American Journal of Cardiology. 2006;98 (9):1248-50. DOI: 10.1016/j.amjcard.2006.06.017Araújo JP, Azevedo A, Lourenço P, Rocha-Gonçalves F, Ferreira A, Bettencourt P. Intraindividual Variation of Amino-Terminal Pro-BType Natriuretic Peptide Levels in Patients with Stable Heart Failure. The American Journal of Cardiology. 2006;98 (9):1248-50. DOI: 10.1016/j.amjcard.2006.06.017Meijers WC, van der Velde AR, Muller Kobold AC, Dijck-Brouwer J, Wu AH, Jaffe A et al. Variability of biomarkers in patients with chronic heart failure and healthy controls. European Journal of Heart Failure. 2017;19 (3):357-65. DOI: 10.1002/ejhf.669Meijers WC, van der Velde AR, Muller Kobold AC, Dijck-Brouwer J, Wu AH, Jaffe A et al. Variability of biomarkers in patients with chronic heart failure and healthy controls. European Journal of Heart Failure. 2017;19 (3):357-65. DOI: 10.1002/ejhf.669Mair J, Falkensammer G, Poelzl G, Hammerer-Lercher A, Griesmacher A, Pachinger O. B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP. Clinica Chimica Acta. 2007;379 (1-2):163-6. DOI: 10.1016/j.cca.2006.12.018Mair J, Falkensammer G, Poelzl G, Hammerer-Lercher A, Griesmacher A, Pachinger O. B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP. Clinica Chimica Acta. 2007;379 (1-2):163-6. DOI: 10.1016/j.cca.2006.12.018Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani M et al. Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. European Heart Journal. 2012;33 (16):2001-6. DOI: 10.1093/eurheartj/ehq509Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani M et al. Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. European Heart Journal. 2012;33 (16):2001-6. DOI: 10.1093/eurheartj/ehq509Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R et al. Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Journal of the American College of Cardiology. 2006;47 (1):91-7. DOI: 10.1016/j.jacc.2005.08.051Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R et al. Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Journal of the American College of Cardiology. 2006;47 (1):91-7. DOI: 10.1016/j.jacc.2005.08.051Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WHW. Timing of Hemoconcentration During Treatment of Acute Decompensated Heart Failure and Subsequent Survival. Journal of the American College of Cardiology. 2013;62 (6):516-24. DOI: 10.1016/j.jacc.2013.05.027Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WHW. Timing of Hemoconcentration During Treatment of Acute Decompensated Heart Failure and Subsequent Survival. Journal of the American College of Cardiology. 2013;62 (6):516-24. DOI: 10.1016/j.jacc.2013.05.027Breidthardt T, Weidmann ZM, Twerenbold R, Gantenbein C, Stallone F, Rentsch K et al. Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function. European Journal of Heart Failure. 2017;19 (2):226- 36. DOI: 10.1002/ejhf.667Breidthardt T, Weidmann ZM, Twerenbold R, Gantenbein C, Stallone F, Rentsch K et al. Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function. European Journal of Heart Failure. 2017;19 (2):226- 36. DOI: 10.1002/ejhf.667Miller WL, Mullan BP. Peripheral Venous Hemoglobin and Red Blood Cell Mass Mismatch in Volume Overload Systolic Heart Failure: Implications for Patient Management. Journal of Cardiovascular Translational Research. 2015;8 (7):404-10. DOI: 10.1007/s12265-015-9650-4Miller WL, Mullan BP. Peripheral Venous Hemoglobin and Red Blood Cell Mass Mismatch in Volume Overload Systolic Heart Failure: Implications for Patient Management. Journal of Cardiovascular Translational Research. 2015;8 (7):404-10. DOI: 10.1007/s12265-015-9650-4Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC et al. Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure. Journal of the American College of Cardiology. 2009;53 (7):589-96. DOI: 10.1016/j.jacc.2008.05.068Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC et al. Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure. Journal of the American College of Cardiology. 2009;53 (7):589-96. DOI: 10.1016/j.jacc.2008.05.068Mebazaa A. Congestion and Cardiorenal Syndromes. Contributions to Nephrology. 2010;165:140-4. DOI: 10.1159/000313752Mebazaa A. Congestion and Cardiorenal Syndromes. Contributions to Nephrology. 2010;165:140-4. DOI: 10.1159/000313752Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R et al. Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance. European Journal of Heart Failure. 2008;10 (2):188-95. DOI: 10.1016/j.ejheart.2008.01.011Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R et al. Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance. European Journal of Heart Failure. 2008;10 (2):188-95. DOI: 10.1016/j.ejheart.2008.01.011Schrier RW. Blood urea nitrogen and serum creatinine: not married in heart failure. Circulation. Heart Failure. 2008;1 (1):2-5. DOI: 10.1161/CIRCHEARTFAILURE.108.770834Schrier RW. Blood urea nitrogen and serum creatinine: not married in heart failure. Circulation. Heart Failure. 2008;1 (1):2-5. DOI: 10.1161/CIRCHEARTFAILURE.108.770834Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. The American Journal of Medicine. 2004;116 (7):466-73. DOI: 10.1016/j.amjmed.2003.11.014Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. The American Journal of Medicine. 2004;116 (7):466-73. DOI: 10.1016/j.amjmed.2003.11.014Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD et al. Prognostic Value of Blood Urea Nitrogen in Patients Hospitalized with Worsening Heart Failure: Insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) Study. Journal of Cardiac Failure. 2007;13 (5):360-4. DOI: 10.1016/j.cardfail.2007.02.005Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD et al. Prognostic Value of Blood Urea Nitrogen in Patients Hospitalized with Worsening Heart Failure: Insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) Study. Journal of Cardiac Failure. 2007;13 (5):360-4. DOI: 10.1016/j.cardfail.2007.02.005Shinagawa H, Inomata T, Koitabashi T, Nakano H, Takeuchi I, Naruke T et al. Prognostic Significance of Increased Serum Bilirubin Levels Coincident with Cardiac Decompensation in Chronic Heart Failure. Circulation Journal. 2008;72 (3):364-9. DOI: 10.1253/circj.72.364Shinagawa H, Inomata T, Koitabashi T, Nakano H, Takeuchi I, Naruke T et al. Prognostic Significance of Increased Serum Bilirubin Levels Coincident with Cardiac Decompensation in Chronic Heart Failure. Circulation Journal. 2008;72 (3):364-9. DOI: 10.1253/circj.72.364Киров М.Ю., Горобец Е.С., Бобовник С.В., Заболотских И.Б., Кохно В.Н., Лебединский К.М. и др. Принципы периоперационной инфузионной терапии у взрослых пациентов. Анестезиология и реаниматология. 2018;63 (6):82- 103. DOI: 10.17116/anaesthesiology201806182Kirov M.Yu., Gorobets E. S., Bobovnik S.V., Zabolotskikh I.B., Kokhno V.N., Lebedinskii K.M. et al. Principles of perioperative infusion therapy in adults. Anesthesiology and Reanimatology. 2018;63 (6):82-103. DOI: 10.17116/anaesthesiology201806182Калашников Р.Н., Недашковский Э.В., Савин П.П., Смирнов А.В. Технические осложнения пункции и функциональная анатомия подключичной вены. Анестезиология и реаниматология. 1991;2:50-4Kalashnikov R.N., Nedashkovskiy E.V., Savin P.P., Smirnov A.V. Technical complications of puncture and functional anatomy of the subclavian vein. Anesthesiology and Reanimatology. 1991;2:50-4.Чибуновский В.А. Центральное венозное давление. Его роль при оценке кровообращения и в контроле инфузионной терапии. Методы его измерения. (Методические рекомендации). - Алматы, 2005. - 19сChibunovsky V.A. Central venous pressure. Its role in the assessment of blood circulation and in the control of infusion therapy. Methods for measuring it. (Methodical recommendations). -Almaty; 2005. - 19 p.Magder S, Bafaqeeh F. The Clinical Role of Central Venous Pressure Measurements. Journal of Intensive Care Medicine. 2007;22 (1):44- 51. DOI: 10.1177/0885066606295303Magder S, Bafaqeeh F. The Clinical Role of Central Venous Pressure Measurements. Journal of Intensive Care Medicine. 2007;22 (1):44- 51. DOI: 10.1177/0885066606295303Сумин С.А. Неотложные состояния. -М.: Медицинское информационное агентство, 2006. -727сSumin S.A. The state of emergency. -M.: Medical Information Agency;2006. - 727 p.Центральное венозное давление (ЦВД). Величина центрального венозного давления (ЦВД). Регуляция цвд. [Internet] Available at: https://meduniver.com/Medical/Physiology/381.htmlMeduniver.com. Central venous pressure (CVP). The value of Central venous pressure (CVP). Regulation of CVD. [Internet] Available at: https://meduniver.com/Medical/Physiology/381.htmlPractice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures. Anesthesiology. 2017;126 (3):376-93. DOI: 10.1097/ALN.0000000000001452Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures. Anesthesiology. 2017;126 (3):376-93. DOI: 10.1097/ALN.0000000000001452Barile L, Fominskiy E, Di Tomasso N, Alpìzar Castro LE, Landoni G, De Luca M et al. Acute Normovolemic Hemodilution Reduces Allogeneic Red Blood Cell Transfusion in Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Trials. Anesthesia & Analgesia. 2017;124 (3):743-52. DOI: 10.1213/ANE.0000000000001609Barile L, Fominskiy E, Di Tomasso N, Alpìzar Castro LE, Landoni G, De Luca M et al. Acute Normovolemic Hemodilution Reduces Allogeneic Red Blood Cell Transfusion in Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Trials. Anesthesia & Analgesia. 2017;124 (3):743-52. DOI: 10.1213/ANE.0000000000001609Ястребов К.М., Кохно В.Н., Локтин Е.М. Основы эхосонографии сердца и легких для анестезиолога-реаниматолога. Новосибирск: ИПО ГАУК НСО НГОНБ, 2016. - 156сYastrebov K.M., Kohno V.N., Loktin E.M. Basics of heart and lung echosonography for an anesthesiologist-resuscitator. -Novosibirsk: SPF GAUCK NSO GONB;2016. - 156 p.Barbier C, Loubières Y, Schmit C, Hayon J, Ricôme J-L, Jardin F et al. Respiratory changes in inferior vena cava diameter are helpful in predicting fluid responsiveness in ventilated septic patients. Intensive Care Medicine. 2004;30 (9):1740-6. DOI: 10.1007/s00134-004-2259-8Barbier C, Loubières Y, Schmit C, Hayon J, Ricôme J-L, Jardin F et al. Respiratory changes in inferior vena cava diameter are helpful in predicting fluid responsiveness in ventilated septic patients. Intensive Care Medicine. 2004;30 (9):1740-6. DOI: 10.1007/s00134-004-2259-8Corl K, Napoli AM, Gardiner F. Bedside sonographic measurement of the inferior vena cava caval index is a poor predictor of fluid responsiveness in emergency department patients. Emergency Medicine Australasia. 2012;24 (5):534-9. DOI: 10.1111/j.1742-6723.2012.01596.xCorl K, Napoli AM, Gardiner F. Bedside sonographic measurement of the inferior vena cava caval index is a poor predictor of fluid responsiveness in emergency department patients. Emergency Medicine Australasia. 2012;24 (5):534-9. DOI: 10.1111/j.1742-6723.2012.01596.xFeissel M, Michard F, Faller J-P, Teboul J-L. The respiratory variation in inferior vena cava diameter as a guide to fluid therapy. Intensive Care Medicine. 2004;30 (9):1834-7. DOI: 10.1007/s00134-004-2233-5Feissel M, Michard F, Faller J-P, Teboul J-L. The respiratory variation in inferior vena cava diameter as a guide to fluid therapy. Intensive Care Medicine. 2004;30 (9):1834-7. DOI: 10.1007/s00134-004-2233-5Mozzini C, Di Dio Perna M, Pesce G, Garbin U, Fratta Pasini AM, Ticinesi A et al. Lung ultrasound in internal medicine efficiently drives the management of patients with heart failure and speeds up the discharge time. Internal and Emergency Medicine. 2018;13 (1):27-33. DOI: 10.1007/s11739-017-1738-1Mozzini C, Di Dio Perna M, Pesce G, Garbin U, Fratta Pasini AM, Ticinesi A et al. Lung ultrasound in internal medicine efficiently drives the management of patients with heart failure and speeds up the discharge time. Internal and Emergency Medicine. 2018;13 (1):27-33. DOI: 10.1007/s11739-017-1738-1Кобалава Ж.Д., Сафарова А.Ф., Кохан Е.В., Исламова М.Р. Статус и перспективы использования ультразвукового исследования легких в оптимизации ведения пациентов с хронической сердечной недостаточностью. Российский кардиологический журнал. 2020;25 (1):97-104. DOI: 10.15829/1560-4071-2020-1-3666Kobalava Zh.D., Safarova A.F., Kokhan E.V., Islamova M.R. Lung ultrasound in optimizing management of patients with heart failure: current status and future prospects. Russian Journal of Cardiology. 2020;25 (1):97-104. DOI: 10.15829/1560-4071-2020-1-3666Muniz RT, Mesquita ET, Souza Junior CV, Martins W de A. Pulmonary Ultrasound in Patients with Heart Failure - Systematic Review. Arquivos Brasileiros de Cardiologia. 2018;110 (6):577-84. DOI: 10.5935/abc.20180097Muniz RT, Mesquita ET, Souza Junior CV, Martins W de A. Pulmonary Ultrasound in Patients with Heart Failure - Systematic Review. Arquivos Brasileiros de Cardiologia. 2018;110 (6):577-84. DOI: 10.5935/abc.20180097Кобалава Ж.Д., Сафарова А.Ф., Соловьева А.E., Кабельо Ф.Е., Мерай И.А., Шаварова Е.К. и др. Легочный застой по данным ультразвукового исследования у пациентов с декомпенсацией сердечной недостаточности. Кардиология. 2019;59 (8):5-14. DOI: 10.18087/cardio.2019.8.n534Kobalava Zh.D., Safarova A.F., Soloveva A.E., Cabello F.E., Meray I.A., Shavarova E.K. et al. Pulmonary congestion by lung ultrasound in decompensated heart failure. Kardiologiia. 2019;59 (8):5- 14. DOI: 10.18087/cardio.2019.8.n534Rivas‐Lasarte M, Álvarez‐García J, Fernández‐Martínez J, Maestro A, López‐López L, Solé‐González E et al. Lung ultrasound‐guided treatment in ambulatory patients with heart failure: a randomized controlled clinical trial (LUS‐HF study). European Journal of Heart Failure. 2019;21 (12):1605-13. DOI: 10.1002/ejhf.1604Rivas‐Lasarte M, Álvarez‐García J, Fernández‐Martínez J, Maestro A, López‐López L, Solé‐González E et al. Lung ultrasound‐guided treatment in ambulatory patients with heart failure: a randomized controlled clinical trial (LUS‐HF study). European Journal of Heart Failure. 2019;21 (12):1605-13. DOI: 10.1002/ejhf.1604Shochat MK, Shotan A, Blondheim DS, Kazatsker M, Dahan I, Asif A et al. Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial). Journal of Cardiac Failure. 2016;22 (9):713-22. DOI: 10.1016/j.cardfail.2016.03.015Shochat MK, Shotan A, Blondheim DS, Kazatsker M, Dahan I, Asif A et al. Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial). Journal of Cardiac Failure. 2016;22 (9):713-22. DOI: 10.1016/j.cardfail.2016.03.015Беленков Ю.Н., Мареев В Ю., Агеев Ф.Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. - М.: ГЭОТАР-Медиа, 2006. - 432с. ISBN 978-5-9704-0119-4Belenkov Yu.N., Mareev V.Yu., Ageev F.T. Chronic heart failure: selected lectures on cardiology. -M.: GEOTAR-Media;2006. - 432 p. ISBN 978-5-9704-0119-4Бизунок Н.А., Гайдук А.В. Мочегонные средства. - Минск: БГМУ, 2016. - 36с. ISBN 978-985-567-557-1Bizunok N.A., Gayduk A.V. Diuretics. -Minsk: BSMU;2016. -36 p. ISBN 978-985-567-557-1Максимов М.Л., Ермолаева А.С., Кучаева А.В. Выбор препарата для диуретической терапии: взгляд клинического фармаколога. Русский Медицинский Журнал. 2018;26 (1-2):115-9Maksimov M.L., Ermolaeva A. S., Kuchaeva A.V. Choice of the drug for the diurethic therapy: a view of a clinical pharmacologist. Russian Medical Journal. 2018;26 (1-2):115-9.Гендлин Г.Е., Рязанцева Е.Е. Современная диуретическая терапия пациентов с хронической сердечной недостаточностью. Атмосфера. Новости кардиологии. 2012;1:18-22Gendlin G.E., Ryazanceva E.E. Modern diuretic therapy for patients with chronic heart failure. Atmosphere. Cardiology news. 2012;1:18-22.Ларина В.Н. Выбор эффективного диуретика для терапии хронической сердечной недостаточности на амбулаторном этапе: доводы в пользу торасемида. Consilium Medicum. 2018;20 (10):29-35. DOI: 10.26442/2075-1753_2018.10.29-35Larina V.N. Choice of effective diuretic for congestive heart failure treatment at the outpatient stage: arguments for torasemide use. Consilium Medicum. 2018;20 (10):29-35. DOI: 10.26442/2075-1753_2018.10.29-35Gropper S, Albet C, Guglietta AA, Gich I, Barbanoj MJ. TDM9 Single-dose, randomized, cross-over, bioavailability pilot clinical trial of torasemide immediate release compared to a new prolonged release formulation of torasemide. Basic and Clinical Pharmacology and Toxicology. 2006;99 (s1):48. [Av. at: https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1742-7843.2006.t01-1-.x]. DOI: 10.1111/j.1742-7843.2006.t01-1-.xGropper S, Albet C, Guglietta AA, Gich I, Barbanoj MJ. TDM9 Single-dose, randomized, cross-over, bioavailability pilot clinical trial of torasemide immediate release compared to a new prolonged release formulation of torasemide. Basic and Clinical Pharmacology and Toxicology. 2006;99 (s1):48. [Av. at: https://onlinelibrary.wiley.com/doi/ epdf/10.1111/j.1742-7843.2006.t01-1-.x]. DOI: 10.1111/j.1742-7843.2006.t01-1-.xMiyata M, Sasaki T, Ikeda Y, Shinsato T, Kubozono T, Furusho Y et al. Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD- CHF). Journal of Cardiology. 2012;59 (3):352-8. DOI: 10.1016/j.jjcc.2011.12.007Miyata M, Sasaki T, Ikeda Y, Shinsato T, Kubozono T, Furusho Y et al. Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD- CHF). Journal of Cardiology. 2012;59 (3):352-8. DOI: 10.1016/j.jjcc.2011.12.007Yamato M, Sasaki T, Honda K, Fukuda M, Akutagawa O, Okamoto M et al. Effects of Torasemide on Left Ventricular Function and Neurohumoral Factors in Patients with Chronic Heart Failure. Circulation Journal. 2003;67 (5):384-90. DOI: 10.1253/circj.67.384Yamato M, Sasaki T, Honda K, Fukuda M, Akutagawa O, Okamoto M et al. Effects of Torasemide on Left Ventricular Function and Neurohumoral Factors in Patients with Chronic Heart Failure. Circulation Journal. 2003;67 (5):384-90. DOI: 10.1253/circj.67.384Агеев Ф.Т., Жубрина Е.С., Гиляревский С.Р., Мареев В.Ю., Хосева Е.Н., Голшмид М.В. Сравнительная эффективность и безопасность длительного применения торасемида и фуросемида у больных с компенсированной сердечной недостаточностью. Влияние на маркеры фиброза миокарда. Журнал Сердечная Недостаточность. 2013;14 (2):55-62Ageev F.T., Zhubrina E. S., Gilyarevskiy S.R., Mareev V.Yu., Khoseva E.N., Golshmid M.V. Comparative efficacy and safety of chronic torasemide and furosemide therapy in patients with compensated heart failure. Effect on markers of myocardial fibrosis. Russian Heart Failure Journal. 2013;14 (2):55-62.Müller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV-efficacy and quality of life. European Journal of Heart Failure. 2003;5 (6):793-801. DOI: 10.1016/S1388-9842(03)00150-8Müller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV-efficacy and quality of life. European Journal of Heart Failure. 2003;5 (6):793-801. DOI: 10.1016/S1388-9842(03)00150-8Мареев В.Ю., Выгодин В.А., Беленков Ю.Н. ДиУретическая терапия Эффективными дозами перораЛЬных диуретиков торасемида (Диувер) и фуросемида в лечении больных с обострением Хронической Сердечной Недостаточности (ДУЭЛЬ - ХСН). Журнал Сердечная Недостаточность. 2011;12 (1):3-10Mareev V.Yu., Vygodin V.A., Belenkov Yu.N. DiUretic therapy with Effective doses of oraL diuretics: torasemide (Diuver®) and furosemide in patients with acute exacerbation of Chronic Heart Failure (DUEL-CHF). Russian Heart Failure Journal. 2011;12 (1):3-10.Cosín J, Díez J, on behalf of the TORIC investigators. Torasemide in chronic heart failure: results of the TORIC study. European Journal of Heart Failure. 2002;4 (4):507-13. DOI: 10.1016/S1388-9842(02)00122-8Cosín J, Díez J, on behalf of the TORIC investigators. Torasemide in chronic heart failure: results of the TORIC study. European Journal of Heart Failure. 2002;4 (4):507-13. DOI: 10.1016/S1388-9842(02)00122-8Ferreira JP, Girerd N, Medeiros PB, Santos M, Carvalho HC, Bettencourt P et al. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect. Clinical Research in Cardiology. 2016;105 (6):489-507. DOI: 10.1007/s00392-015-0945-xFerreira JP, Girerd N, Medeiros PB, Santos M, Carvalho HC, Bettencourt P et al. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect. Clinical Research in Cardiology. 2016;105 (6):489-507. DOI: 10.1007/s00392-015-0945-xSwedberg K, Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Shi H et al. Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and SurvIval Study in Heart Failure) study. Journal of the American College of Cardiology. 2012;59 (18):1598-603. DOI: 10.1016/j.jacc.2011.11.063Swedberg K, Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Shi H et al. Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and SurvIval Study in Heart Failure) study. Journal of the American College of Cardiology. 2012;59 (18):1598-603. DOI: 10.1016/j.jacc.2011.11.063Verbrugge FH, Grieten L, Mullens W. Management of the Cardiorenal Syndrome in Decompensated Heart Failure. Cardiorenal Medicine. 2014;4 (3-4):176-88. DOI: 10.1159/000366168Verbrugge FH, Grieten L, Mullens W. Management of the Cardiorenal Syndrome in Decompensated Heart Failure. Cardiorenal Medicine. 2014;4 (3-4):176-88. DOI: 10.1159/000366168Jones P, Greenstone M. Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2001;2001 (1):CD002881. DOI: 10.1002/14651858.CD002881Jones P, Greenstone M. Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2001;2001 (1):CD002881. DOI: 10.1002/14651858.CD002881Philippi H, Bieber I, Reitter B. Acetazolamide Treatment for Infantile Central Sleep Apnea. Journal of Child Neurology. 2001;16 (8):600-3. DOI: 10.1177/088307380101600813Philippi H, Bieber I, Reitter B. Acetazolamide Treatment for Infantile Central Sleep Apnea. Journal of Child Neurology. 2001;16 (8):600-3. DOI: 10.1177/088307380101600813Javaheri S. Acetazolamide Improves Central Sleep Apnea in Heart Failure: A Double-Blind, Prospective Study. American Journal of Respiratory and Critical Care Medicine. 2006;173 (2):234-7. DOI: 10.1164/rccm.200507-1035OCJavaheri S. Acetazolamide Improves Central Sleep Apnea in Heart Failure: A Double-Blind, Prospective Study. American Journal of Respiratory and Critical Care Medicine. 2006;173 (2):234-7. DOI: 10.1164/rccm.200507-1035OCFerreira JP, Girerd N, Bettencourt Medeiros P, Bento Ricardo M, Almeida T, Rola A et al. Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality. Cardiorenal Medicine. 2017;7 (2):137-49. DOI: 10.1159/000455903Ferreira JP, Girerd N, Bettencourt Medeiros P, Bento Ricardo M, Almeida T, Rola A et al. Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality. Cardiorenal Medicine. 2017;7 (2):137-49. DOI: 10.1159/000455903Brinkley DM, Burpee LJ, Chaudhry S-P, Smallwood JA, Lindenfeld J, Lakdawala NK et al. Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit. Journal of Cardiac Failure. 2018;24 (6):349-54. DOI: 10.1016/j.cardfail.2018.01.009Brinkley DM, Burpee LJ, Chaudhry S-P, Smallwood JA, Lindenfeld J, Lakdawala NK et al. Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit. Journal of Cardiac Failure. 2018;24 (6):349-54. DOI: 10.1016/j.cardfail.2018.01.009Singh D, Shrestha K, Testani JM, Verbrugge FH, Dupont M, Mullens W et al. Insufficient Natriuretic Response to Continuous Intravenous Furosemide Is Associated With Poor Long-Term Outcomes in Acute Decompensated Heart Failure. Journal of Cardiac Failure. 2014;20 (6):392-9. DOI: 10.1016/j.cardfail.2014.03.006Singh D, Shrestha K, Testani JM, Verbrugge FH, Dupont M, Mullens W et al. Insufficient Natriuretic Response to Continuous Intravenous Furosemide Is Associated With Poor Long-Term Outcomes in Acute Decompensated Heart Failure. Journal of Cardiac Failure. 2014;20 (6):392-9. DOI: 10.1016/j.cardfail.2014.03.006Testani JM, Hanberg JS, Cheng S, Rao V, Onyebeke C, Laur O et al. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure. Circulation: Heart Failure. 2016;9 (1):e002370. DOI: 10.1161/CIRCHEARTFAILURE.115.002370Testani JM, Hanberg JS, Cheng S, Rao V, Onyebeke C, Laur O et al. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure. Circulation: Heart Failure. 2016;9 (1):e002370. DOI: 10.1161/CIRCHEARTFAILURE.115.002370Luk A, Groarke JD, Desai AS, Mahmood SS, Gopal DM, Joyce E et al. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization. American Heart Journal. 2018;203:95-100. DOI: 10.1016/j.ahj.2018.01.013Luk A, Groarke JD, Desai AS, Mahmood SS, Gopal DM, Joyce E et al. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization. American Heart Journal. 2018;203:95-100. DOI: 10.1016/j.ahj.2018.01.013Collins SP, Jenkins CA, Baughman A, Miller KF, Storrow AB, Han JH et al. Early urine electrolyte patterns in patients with acute heart failure: Urine electrolytes and worsening heart failure. ESC Heart Failure. 2019;6 (1):80-8. DOI: 10.1002/ehf2.12368Collins SP, Jenkins CA, Baughman A, Miller KF, Storrow AB, Han JH et al. Early urine electrolyte patterns in patients with acute heart failure: Urine electrolytes and worsening heart failure. ESC Heart Failure. 2019;6 (1):80-8. DOI: 10.1002/ehf2.12368Cox ZL, Testani JM. Loop diuretic resistance complicating acute heart failure. Heart Failure Reviews. 2020;25 (1):133-45. DOI: 10.1007/s10741-019-09851-9Cox ZL, Testani JM. Loop diuretic resistance complicating acute heart failure. Heart Failure Reviews. 2020;25 (1):133-45. DOI: 10.1007/s10741-019-09851-9Verbrugge FH, Nijst P, Dupont M, Penders J, Tang WHW, Mullens W. Urinary Composition During Decongestive Treatment in Heart Failure with Reduced Ejection Fraction. Circulation: Heart Failure. 2014;7 (5):766-72. DOI: 10.1161/CIRCHEARTFAILURE.114.001377Verbrugge FH, Nijst P, Dupont M, Penders J, Tang WHW, Mullens W. Urinary Composition During Decongestive Treatment in Heart Failure with Reduced Ejection Fraction. Circulation: Heart Failure. 2014;7 (5):766-72. DOI: 10.1161/CIRCHEARTFAILURE.114.001377Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic Therapy for Patients with Heart Failure. Journal of the American College of Cardiology. 2020;75 (10):1178-95. DOI: 10.1016/j. jacc.2019.12.059Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic Therapy for Patients with Heart Failure. Journal of the American College of Cardiology. 2020;75 (10):1178-95. DOI: 10.1016/j. jacc.2019.12.059Bock JS, Gottlieb SS. Cardiorenal Syndrome: New Perspectives. Circulation. 2010;121 (23):2592-600. DOI: 10.1161/CIRCULATIONAHA.109.886473Bock JS, Gottlieb SS. Cardiorenal Syndrome: New Perspectives. Circulation. 2010;121 (23):2592-600. DOI: 10.1161/CIRCULATIONAHA.109.886473Gottlieb SS, Stebbins A, Voors AA, Hasselblad V, Ezekowitz JA, Califf RM et al. Effects of Nesiritide and Predictors of Urine Output in Acute Decompensated Heart Failure. Journal of the American College of Cardiology. 2013;62 (13):1177-83. DOI: 10.1016/j.jacc.2013.04.073Gottlieb SS, Stebbins A, Voors AA, Hasselblad V, Ezekowitz JA, Califf RM et al. Effects of Nesiritide and Predictors of Urine Output in Acute Decompensated Heart Failure. Journal of the American College of Cardiology. 2013;62 (13):1177-83. DOI: 10.1016/j.jacc.2013.04.073Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287 (12):1541-7. DOI: 10.1001/jama.287.12.1541Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287 (12):1541-7. DOI: 10.1001/jama.287.12.1541Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial. JAMA. 2013;310 (23):2533-43. DOI: 10.1001/jama.2013.282190Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial. JAMA. 2013;310 (23):2533-43. DOI: 10.1001/jama.2013.282190Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. The Lancet. 2013;381 (9860):29-39. DOI: 10.1016/S0140-6736 (12) 61855-8Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. The Lancet. 2013;381 (9860):29-39. DOI: 10.1016/S0140-6736 (12) 61855-8Chen HH, Redfield MM, Nordstrom LJ, Cataliotti A, Burnett JC. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure. American Journal of Physiology-Renal Physiology. 2003;284 (5):F1115-9. DOI: 10.1152/ajprenal.00337.2002Chen HH, Redfield MM, Nordstrom LJ, Cataliotti A, Burnett JC. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure. American Journal of Physiology-Renal Physiology. 2003;284 (5):F1115-9. DOI: 10.1152/ajprenal.00337.2002Kula AJ, Hanberg JS, Wilson FP, Brisco MA, Bellumkonda L, Jacoby D et al. Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure. Circulation: Heart Failure. 2016;9 (1):e002333. DOI: 10.1161/CIRCHEARTFAILURE.115.002333Kula AJ, Hanberg JS, Wilson FP, Brisco MA, Bellumkonda L, Jacoby D et al. Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure. Circulation: Heart Failure. 2016;9 (1):e002333. DOI: 10.1161/CIRCHEARTFAILURE.115.002333Brater DC. Diuretic Therapy. New England Journal of Medicine. 1998;339 (6):387-95. DOI: 10.1056/NEJM199808063390607Brater DC. Diuretic Therapy. New England Journal of Medicine. 1998;339 (6):387-95. DOI: 10.1056/NEJM199808063390607Aliti GB, Rabelo ER, Clausell N, Rohde LE, Biolo A, Beck-da-Silva L. Aggressive Fluid and Sodium Restriction in Acute Decompensated Heart Failure: A Randomized Clinical Trial. JAMA Internal Medicine. 2013;173 (12):1058. DOI: 10.1001/jamainternmed.2013.552Aliti GB, Rabelo ER, Clausell N, Rohde LE, Biolo A, Beck-da-Silva L. Aggressive Fluid and Sodium Restriction in Acute Decompensated Heart Failure: A Randomized Clinical Trial. JAMA Internal Medicine. 2013;173 (12):1058. DOI: 10.1001/jamainternmed.2013.552Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. European Journal of Heart Failure. 2000;2 (3):305-13. DOI: 10.1016/S1388-9842 (00) 00094-5Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. European Journal of Heart Failure. 2000;2 (3):305-13. DOI: 10.1016/S1388-9842 (00) 00094-5Licata G, Pasquale PD, Parrinello G, Cardinale A, Scandurra A, Follone G et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects. American Heart Journal. 2003;145 (3):459-66. DOI: 10.1067/mhj.2003.166Licata G, Pasquale PD, Parrinello G, Cardinale A, Scandurra A, Follone G et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects. American Heart Journal. 2003;145 (3):459-66. DOI: 10.1067/mhj.2003.166Griffin M, Soufer A, Goljo E, Colna M, Rao VS, Jeon S et al. Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure. JACC: Heart Failure. 2020;8 (3):199-208. DOI: 10.1016/j.jchf.2019.10.012Griffin M, Soufer A, Goljo E, Colna M, Rao VS, Jeon S et al. Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure. JACC: Heart Failure. 2020;8 (3):199-208. DOI: 10.1016/j.jchf.2019.10.012Wilcox CS. New insights into diuretic use in patients with chronic renal disease. Journal of the American Society of Nephrology: JASN. 2002;13 (3):798-805. PMID: 11856788Wilcox CS. New insights into diuretic use in patients with chronic renal disease. Journal of the American Society of Nephrology: JASN. 2002;13 (3):798-805. PMID: 11856788Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR et al. Loop Diuretic Efficiency: A Metric of Diuretic Responsiveness with Prognostic Importance in Acute Decompensated Heart Failure. Circulation: Heart Failure. 2014;7 (2):261-70. DOI: 10.1161/CIRCHEARTFAILURE.113.000895Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR et al. Loop Diuretic Efficiency: A Metric of Diuretic Responsiveness with Prognostic Importance in Acute Decompensated Heart Failure. Circulation: Heart Failure. 2014;7 (2):261-70. DOI: 10.1161/CIRCHEARTFAILURE.113.000895ter Maaten JM, Dunning AM, Valente MAE, Damman K, Ezekowitz JA, Califf RM et al. Diuretic response in acute heart failure-an analysis from ASCEND-HF. American Heart Journal. 2015;170 (2):313- 21. DOI: 10.1016/j.ahj.2015.05.003ter Maaten JM, Dunning AM, Valente MAE, Damman K, Ezekowitz JA, Califf RM et al. Diuretic response in acute heart failure-an analysis from ASCEND-HF. American Heart Journal. 2015;170 (2):313- 21. DOI: 10.1016/j.ahj.2015.05.003ter Maaten JM, Rao VS, Hanberg JS, Perry Wilson F, Bellumkonda L, Assefa M et al. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure: Tubular resistance and diuretic resistance in AHF. European Journal of Heart Failure. 2017;19 (8):1014-22. DOI: 10.1002/ejhf.757ter Maaten JM, Rao VS, Hanberg JS, Perry Wilson F, Bellumkonda L, Assefa M et al. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure: Tubular resistance and diuretic resistance in AHF. European Journal of Heart Failure. 2017;19 (8):1014-22. DOI: 10.1002/ejhf.757Hanberg JS, Rao V, ter Maaten JM, Laur O, Brisco MA, Perry Wilson F et al. Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights. Circulation: Heart Failure. 2016;9 (8):e003180. DOI: 10.1161/CIRCHEARTFAILURE.116.003180Hanberg JS, Rao V, ter Maaten JM, Laur O, Brisco MA, Perry Wilson F et al. Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights. Circulation: Heart Failure. 2016;9 (8):e003180. DOI: 10.1161/CIRCHEARTFAILURE.116.003180Jentzer JC, DeWald TA, Hernandez AF. Combination of Loop Diuretics with Thiazide-Type Diuretics in Heart Failure. Journal of the American College of Cardiology. 2010;56 (19):1527-34. DOI: 10.1016/j.jacc.2010.06.034Jentzer JC, DeWald TA, Hernandez AF. Combination of Loop Diuretics with Thiazide-Type Diuretics in Heart Failure. Journal of the American College of Cardiology. 2010;56 (19):1527-34. DOI: 10.1016/j.jacc.2010.06.034Bart BA, Goldsmith SR, Lee KL, Redfield MM, Felker GM, O’Connor CM et al. Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Rationale and Design of CARRESS-HF, for the Heart Failure Clinical Research Network. Journal of Cardiac Failure. 2012;18 (3):176-82. DOI: 10.1016/j.cardfail.2011.12.009Bart BA, Goldsmith SR, Lee KL, Redfield MM, Felker GM, O’Connor CM et al. Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Rationale and Design of CARRESS-HF, for the Heart Failure Clinical Research Network. Journal of Cardiac Failure. 2012;18 (3):176-82. DOI: 10.1016/j.cardfail.2011.12.009Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA et al. Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome. New England Journal of Medicine. 2012;367 (24):2296-304. DOI: 10.1056/NEJMoa1210357Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA et al. Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome. New England Journal of Medicine. 2012;367 (24):2296-304. DOI: 10.1056/NEJMoa1210357Mullens W, Verbrugge FH, Nijst P, Martens P, Tartaglia K, Theunissen E et al. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial. European Journal of Heart Failure. 2018;20 (11):1591-600. DOI: 10.1002/ejhf.1307Mullens W, Verbrugge FH, Nijst P, Martens P, Tartaglia K, Theunissen E et al. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial. European Journal of Heart Failure. 2018;20 (11):1591-600. DOI: 10.1002/ejhf.1307Wan S-H, Stevens SR, Borlaug BA, Anstrom KJ, Deswal A, Felker GM et al. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure with Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circulation: Heart Failure. 2016;9 (8):e002593. DOI: 10.1161/CIRCHEARTFAILURE.115.002593Wan S-H, Stevens SR, Borlaug BA, Anstrom KJ, Deswal A, Felker GM et al. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure with Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circulation: Heart Failure. 2016;9 (8):e002593. DOI: 10.1161/CIRCHEARTFAILURE.115.002593Felker GM, Mentz RJ, Cole RT, Adams KF, Egnaczyk GF, Fiuzat M et al. Efficacy and Safety of Tolvaptan in Patients Hospitalized with Acute Heart Failure. Journal of the American College of Cardiology. 2017;69 (11):1399-406. DOI: 10.1016/j.jacc.2016.09.004Felker GM, Mentz RJ, Cole RT, Adams KF, Egnaczyk GF, Fiuzat M et al. Efficacy and Safety of Tolvaptan in Patients Hospitalized with Acute Heart Failure. Journal of the American College of Cardiology. 2017;69 (11):1399-406. DOI: 10.1016/j.jacc.2016.09.004McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. New England Journal of Medicine. 2019;381 (21):1995-2008. DOI: 10.1056/NEJMoa1911303McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. New England Journal of Medicine. 2019;381 (21):1995-2008. DOI: 10.1056/NEJMoa1911303Dossetor JB. Creatininemia Versus Uremia: The Relative Significance of Blood Urea Nitrogen and Serum Creatinine Concentrations in Azotemia. Annals of Internal Medicine. 1966;65 (6):1287-99. DOI: 10.7326/0003-4819-65-6-1287Dossetor JB. Creatininemia Versus Uremia: The Relative Significance of Blood Urea Nitrogen and Serum Creatinine Concentrations in Azotemia. Annals of Internal Medicine. 1966;65 (6):1287-99. DOI: 10.7326/0003-4819-65-6-1287Spital A. Diuretic-Induced Hyponatremia. American Journal of Nephrology. 1999;19 (4):447-52. DOI: 10.1159/000013496Spital A. Diuretic-Induced Hyponatremia. American Journal of Nephrology. 1999;19 (4):447-52. DOI: 10.1159/000013496Sica DA. Diuretic‐Related Side Effects: Development and Treatment. The Journal of Clinical Hypertension. 2004;6 (9):532-40. DOI: 10.1111/j.1524-6175.2004.03789.xSica DA. Diuretic‐Related Side Effects: Development and Treatment. The Journal of Clinical Hypertension. 2004;6 (9):532-40. DOI: 10.1111/j.1524-6175.2004.03789.xDiuretics IV: chemistry, pharmacology, and clinical applications: proceedings of the Fourth International Conference on Diuretics, Boca Raton, Florida, U. S. A., 11-16 October 1992. Puschett JB, Greenberg A, editors -Amsterdam; New York: Excerpta Medica;1993. - 899 p. [Fernandez P, Choi M. Thiazide-induced hyponatraemia. P. 199- 209]. ISBN 978-0-444-89630-8Diuretics IV: chemistry, pharmacology, and clinical applications: proceedings of the Fourth International Conference on Diuretics, Boca Raton, Florida, U. S. A., 11-16 October 1992. Puschett JB, Greenberg A, editors -Amsterdam; New York: Excerpta Medica;1993. - 899 p. [Fernandez P, Choi M. Thiazide-induced hyponatraemia. P. 199- 209]. ISBN 978-0-444-89630-8Byatt CM, Millard PH, Levin GE. Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. Journal of the Royal Society of Medicine. 1990;83 (11):704-8. PMID: 2250268Byatt CM, Millard PH, Levin GE. Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. Journal of the Royal Society of Medicine. 1990;83 (11):704-8. PMID: 2250268Osadchii OE. Mechanisms of hypokalemia-induced ventricular arrhythmogenicity: Hypokalemia and tachyarrhythmia. Fundamental & Clinical Pharmacology. 2010;24 (5):547-59. DOI: 10.1111/j.1472-8206.2010.00835.xOsadchii OE. Mechanisms of hypokalemia-induced ventricular arrhythmogenicity: Hypokalemia and tachyarrhythmia. Fundamental & Clinical Pharmacology. 2010;24 (5):547-59. DOI: 10.1111/j.1472-8206.2010.00835.xKuvin JT. Electrocardiographic Changes of Hyperkalemia. New England Journal of Medicine. 1998;338 (10):662. DOI: 10.1056/NEJM199803053381005Kuvin JT. Electrocardiographic Changes of Hyperkalemia. New England Journal of Medicine. 1998;338 (10):662. DOI: 10.1056/NEJM199803053381005Weiner ID, Wingo CS. Hypokalemia--consequences, causes, and correction. Journal of the American Society of Nephrology. 1997;8 (7):1179-88. PMID: 9219169Weiner ID, Wingo CS. Hypokalemia--consequences, causes, and correction. Journal of the American Society of Nephrology. 1997;8 (7):1179-88. PMID: 9219169Gennari FJ. Hypokalemia. New England Journal of Medicine. 1998;339 (7):451-8. DOI: 10.1056/NEJM199808133390707Gennari FJ. Hypokalemia. New England Journal of Medicine. 1998;339 (7):451-8. DOI: 10.1056/NEJM199808133390707Loon NR, Wilcox CS. Mild Metabolic Alkalosis Impairs the Natriuretic Response to Bumetanide in Normal Human Subjects. Clinical Science. 1998;94 (3):287-92. DOI: 10.1042/cs0940287Loon NR, Wilcox CS. Mild Metabolic Alkalosis Impairs the Natriuretic Response to Bumetanide in Normal Human Subjects. Clinical Science. 1998;94 (3):287-92. DOI: 10.1042/cs0940287Taal MW, Brenner BM, Rector FC. Brenner and Rector’s the kidney. 9th Edition. E-Book. -Imprint: Saunders;2012. ISBN 978-1-4160-6193-9Taal MW, Brenner BM, Rector FC. Brenner and Rector’s the kidney. 9th Edition. E-Book. -Imprint: Saunders;2012. ISBN 978-1-4160-6193-9Alexander RT, Dimke H. Effect of diuretics on renal tubular transport of calcium and magnesium. American Journal of PhysiologyRenal Physiology. 2017;312 (6):F998-1015. DOI: 10.1152/ajprenal.00032.2017Alexander RT, Dimke H. Effect of diuretics on renal tubular transport of calcium and magnesium. American Journal of PhysiologyRenal Physiology. 2017;312 (6):F998-1015. DOI: 10.1152/ajprenal.00032.2017Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop Diuretics Increase Bone Turnover and Decrease BMD in Osteopenic Postmenopausal Women: Results from a Randomized Controlled Study with Bumetanide. Journal of Bone and Mineral Research. 2005;21 (1):163-70. DOI: 10.1359/JBMR.051003Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop Diuretics Increase Bone Turnover and Decrease BMD in Osteopenic Postmenopausal Women: Results from a Randomized Controlled Study with Bumetanide. Journal of Bone and Mineral Research. 2005;21 (1):163-70. DOI: 10.1359/JBMR.051003Wermers RA, Kearns AE, Jenkins GD, Melton LJ. Incidence and Clinical Spectrum of Thiazide-associated Hypercalcemia. The American Journal of Medicine. 2007;120 (10):911.e9-911.e15. DOI: 10.1016/j.amjmed.2006.07.044Wermers RA, Kearns AE, Jenkins GD, Melton LJ. Incidence and Clinical Spectrum of Thiazide-associated Hypercalcemia. The American Journal of Medicine. 2007;120 (10):911.e9-911.e15. DOI: 10.1016/j.amjmed.2006.07.044Hakim R, Tolis G, Goltzman D, Meltzer S, Friedman R. Severe hypercalcemia associated with hydrochlorothiazide and calcium carbonate therapy. Canadian Medical Association Journal. 1979;121 (5):591-4. PMID: 497950Hakim R, Tolis G, Goltzman D, Meltzer S, Friedman R. Severe hypercalcemia associated with hydrochlorothiazide and calcium carbonate therapy. Canadian Medical Association Journal. 1979;121 (5):591-4. PMID: 497950Waller PC, Ramsay LE. Predicting acute gout in diuretic-treated hypertensive patients. Journal of Human Hypertension. 1989;3 (6):457- 61. PMID: 2607519Waller PC, Ramsay LE. Predicting acute gout in diuretic-treated hypertensive patients. Journal of Human Hypertension. 1989;3 (6):457- 61. PMID: 2607519Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37 (27):2129-200. DOI: 10.1093/eurheartj/ehw128Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37 (27):2129-200. DOI: 10.1093/eurheartj/ehw128Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J et al. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 2015;131 (20):1763-71. DOI: 10.1161/CIRCULATIONAHA.114.014536Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J et al. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 2015;131 (20):1763-71. DOI: 10.1161/CIRCULATIONAHA.114.014536Pavlusova M, Jarkovsky J, Benesova K, Vitovec J, Linhart A, Widimsky P et al. Hyperuricemia treatment in acute heart failure patients does not improve their long‐term prognosis: A propensity score matched analysis from the AHEAD registry. Clinical Cardiology. 2019;42 (8):720-7. DOI: 10.1002/clc.23197Pavlusova M, Jarkovsky J, Benesova K, Vitovec J, Linhart A, Widimsky P et al. Hyperuricemia treatment in acute heart failure patients does not improve their long‐term prognosis: A propensity score matched analysis from the AHEAD registry. Clinical Cardiology. 2019;42 (8):720-7. DOI: 10.1002/clc.23197Ames RP. The Effects of Antihypertensive Drugs on Serum Lipids and Lipoproteins: II. Non-Diuretic Drugs. Drugs. 1986;32 (4):335-57. DOI: 10.2165/00003495-198632040-00003Ames RP. The Effects of Antihypertensive Drugs on Serum Lipids and Lipoproteins: II. Non-Diuretic Drugs. Drugs. 1986;32 (4):335-57. DOI: 10.2165/00003495-198632040-00003Ott SM, LaCroix AZ, Ichikawa LE, Scholes D, Barlow WE. Effect of Low-Dose Thiazide Diuretics on Plasma Lipids: Results from a Double-Blind, Randomized Clinical Trial in Older Men and Women. Journal of the American Geriatrics Society. 2003;51 (3):340-7. DOI: 10.1046/j.1532-5415.2003.51107.xOtt SM, LaCroix AZ, Ichikawa LE, Scholes D, Barlow WE. Effect of Low-Dose Thiazide Diuretics on Plasma Lipids: Results from a Double-Blind, Randomized Clinical Trial in Older Men and Women. Journal of the American Geriatrics Society. 2003;51 (3):340-7. DOI: 10.1046/j.1532-5415.2003.51107.xVerdecchia P, Reboldi G, Angeli F, Borgioni C, Gattobigio R, Filippucci L et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension. 2004;43 (5):963-9. DOI: 10.1161/01.HYP.0000125726.92964.abVerdecchia P, Reboldi G, Angeli F, Borgioni C, Gattobigio R, Filippucci L et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension. 2004;43 (5):963-9. DOI: 10.1161/01.HYP.0000125726.92964.abFogari R, Zoppi A. Effects of antihypertensive therapy on sexual activity in hypertensive men. Current Hypertension Reports. 2002;4 (3):202-10. DOI: 10.1007/s11906-002-0008-3Fogari R, Zoppi A. Effects of antihypertensive therapy on sexual activity in hypertensive men. Current Hypertension Reports. 2002;4 (3):202-10. DOI: 10.1007/s11906-002-0008-3Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, Pottegård A. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. Journal of the American Academy of Dermatology. 2018;78 (4):673-681.e9. DOI: 10.1016/j.jaad.2017.11.042Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, Pottegård A. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. Journal of the American Academy of Dermatology. 2018;78 (4):673-681.e9. DOI: 10.1016/j.jaad.2017.11.042Nicholls MG. Interaction of diuretics and electrolytes in congestive heart failure. The American Journal of Cardiology. 1990;65 (10):17E21E; discussion 22E-23E. DOI: 10.1016/0002-9149 (90) 90246-wNicholls MG. Interaction of diuretics and electrolytes in congestive heart failure. The American Journal of Cardiology. 1990;65 (10):17E21E; discussion 22E-23E. DOI: 10.1016/0002-9149 (90) 90246-wAronson JK. Meylers side effects of drugs - the international encyclopedia of adverse drug reactions and interactions. 16th Edition. -Imprint: Elsevier Science;2015. - 7674 p. ISBN 978-0-444-53717-1Aronson JK. Meylers side effects of drugs - the international encyclopedia of adverse drug reactions and interactions. 16th Edition. -Imprint: Elsevier Science;2015. - 7674 p. ISBN 978-0-444-53717-1Каюков И.Г., Лукичёв Б.Г., Подгаецкая О.Ю. К вопросу о так называемой фуросемидзависимой почке. Новые Санкт-Петербургские врачебные ведомости. 2009;2:92-3Kayukov I.G., Lukichev B.G., Podgaetskaya O.Yu. To the question of the so-called furosemide-dependent kidney. New St. Petersburg medical records. 2009;2:92-3.Рябов С.И. Нефрология: руководство для врачей: в 2 т. Т.2: Почечная недостаточность. - СПб.: СпецЛит, 2013. - 232с. ISBN 978-5-299-00501-1Ryabov S.I. Nephrology: a guide for doctors: in 2 vols. T. 2: Kidney failure. -SPb.: SpecLit;2013. - 232 p. ISBN 978-5-299-00501-1Parfitt AM. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis; relationship to citrate and calcium excretion. Archives of Internal Medicine. 1969;124 (6):736-40. PMID: 5353483Parfitt AM. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis; relationship to citrate and calcium excretion. Archives of Internal Medicine. 1969;124 (6):736-40. PMID: 5353483Mallette LE. Acetazolamide-accelerated anticonvulsant osteomalacia. Archives of Internal Medicine. 1977;137 (8):1013-7. PMID: 879939Mallette LE. Acetazolamide-accelerated anticonvulsant osteomalacia. Archives of Internal Medicine. 1977;137 (8):1013-7. PMID: 879939Carone L, Oxberry SG, Twycross R, Charlesworth S, Mihalyo M, Wilcock A. Furosemide. Journal of Pain and Symptom Management. 2016;52 (1):144-50. DOI: 10.1016/j.jpainsymman.2016.05.004Carone L, Oxberry SG, Twycross R, Charlesworth S, Mihalyo M, Wilcock A. Furosemide. Journal of Pain and Symptom Management. 2016;52 (1):144-50. DOI: 10.1016/j.jpainsymman.2016.05.004Müller FO, Middle MV, Schall R, Terblanché J, Hundt HKL, Groenewoud G. An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure. British Journal of Clinical Pharmacology. 1997;44 (4):393-8. DOI: 10.1046/j.1365-2125.1997.t01-1-00586.xMüller FO, Middle MV, Schall R, Terblanché J, Hundt HKL, Groenewoud G. An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure. British Journal of Clinical Pharmacology. 1997;44 (4):393-8. DOI: 10.1046/j.1365-2125.1997.t01-1-00586.xLai S, Momper JD, Yam FK. Evaluation of the effect of torsemide on warfarin dosage requirements. International Journal of Clinical Pharmacy. 2017;39 (4):831-5. DOI: 10.1007/s11096-017-0479-6Lai S, Momper JD, Yam FK. Evaluation of the effect of torsemide on warfarin dosage requirements. International Journal of Clinical Pharmacy. 2017;39 (4):831-5. DOI: 10.1007/s11096-017-0479-6Li J, Xu S, Yang L, Yang J, Wang CJ, Weinstein AM et al. Sex difference in kidney electrolyte transport II: impact of K+ intake on thiazidesensitive cation excretion in male and female mice. American Journal of Physiology-Renal Physiology. 2019;317 (4):F967-77. DOI: 10.1152/ajprenal.00125.2019Li J, Xu S, Yang L, Yang J, Wang CJ, Weinstein AM et al. Sex difference in kidney electrolyte transport II: impact of K+ intake on thiazidesensitive cation excretion in male and female mice. American Journal of Physiology-Renal Physiology. 2019;317 (4):F967-77. DOI: 10.1152/ajprenal.00125.2019Rasmussen TP, Williford NN, DeZorzi C, Hammoud A, Boyle BJ, Zhou Y et al. Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men. Cardiology Research and Practice. 2019;2019:1505142. DOI: 10.1155/2019/1505142Rasmussen TP, Williford NN, DeZorzi C, Hammoud A, Boyle BJ, Zhou Y et al. Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men. Cardiology Research and Practice. 2019;2019:1505142. DOI: 10.1155/2019/1505142Werner U, Werner D, Heinbüchner S, Graf B, Ince H, Kische S et al. Gender Is an Important Determinant of the Disposition of the Loop Diuretic Torasemide. The Journal of Clinical Pharmacology. 2010;50 (2):160-8. DOI: 10.1177/0091270009337514Werner U, Werner D, Heinbüchner S, Graf B, Ince H, Kische S et al. Gender Is an Important Determinant of the Disposition of the Loop Diuretic Torasemide. The Journal of Clinical Pharmacology. 2010;50 (2):160-8. DOI: 10.1177/0091270009337514Sica DA, Gehr TWB, Frishman WH. Use of Diuretics in the Treatment of Heart Failure in Older Adults. Heart Failure Clinics. 2017;13 (3):503-12. DOI: 10.1016/j.hfc.2017.02.006Sica DA, Gehr TWB, Frishman WH. Use of Diuretics in the Treatment of Heart Failure in Older Adults. Heart Failure Clinics. 2017;13 (3):503-12. DOI: 10.1016/j.hfc.2017.02.006Cunha FM, Pereira J, Marques P, Ribeiro A, Bettencourt P, Lourenço P. Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients. Journal of Cardiovascular Medicine. 2020;21 (1):21-6. DOI: 10.2459/JCM.0000000000000896Cunha FM, Pereira J, Marques P, Ribeiro A, Bettencourt P, Lourenço P. Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients. Journal of Cardiovascular Medicine. 2020;21 (1):21-6. DOI: 10.2459/JCM.0000000000000896Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, BlomströmLundqvist C, Cífková R, De Bonis M et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal. 2018;39 (34):3165-241. DOI: 10.1093/eurheartj/ehy340Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, BlomströmLundqvist C, Cífková R, De Bonis M et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal. 2018;39 (34):3165-241. DOI: 10.1093/eurheartj/ehy340Fiaccadori F, Pedretti G, Pasetti G, Pizzaferri P, Elia G. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study. The Clinical Investigator. 1993;71 (7):579-84. DOI: 10.1007/BF00208486Fiaccadori F, Pedretti G, Pasetti G, Pizzaferri P, Elia G. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study. The Clinical Investigator. 1993;71 (7):579-84. DOI: 10.1007/BF00208486Abecasis R, Guevara M, Miguez C, Cobas S, Terg R. Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites. Scandinavian Journal of Gastroenterology. 2001;36 (3):309-13. DOI: 10.1080/003655201750074672Abecasis R, Guevara M, Miguez C, Cobas S, Terg R. Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites. Scandinavian Journal of Gastroenterology. 2001;36 (3):309-13. DOI: 10.1080/003655201750074672Gotsman I, Shauer A, Zwas DR, Tahiroglu I, Lotan C, Keren A. Low serum albumin: A significant predictor of reduced survival in patients with chronic heart failure. Clinical Cardiology. 2019;42 (3):365-72. DOI: 10.1002/clc.23153Gotsman I, Shauer A, Zwas DR, Tahiroglu I, Lotan C, Keren A. Low serum albumin: A significant predictor of reduced survival in patients with chronic heart failure. Clinical Cardiology. 2019;42 (3):365-72. DOI: 10.1002/clc.23153Моисеев В.С., Мухин Н.А., Смирнов А.В., Кобалава Ж.Д., Бобкова И.Н., Виллевальде С.В. и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Российский кардиологический журнал. 2014;19 (8):7-37. DOI: 10.15829/1560-4071-2014-8-7-37Moiseev V. S., Mukhin N.A., Smirnov A.V., Kobalava Zh.D., Bobkova I.N., Villevalde S.V. et al. Cardiovascular risk and chronic kidney disease: cardio-nephroprotection strategies. Russian Journal of Cardiology. 2014;19 (8):7-37. DOI: 10.15829/1560-4071-2014-8-7-37Mullens W, Damman K, Testani JM, Martens P, Mueller C, Lassus J et al. Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2020;22 (4):584-603. DOI: 10.1002/ejhf.1697Mullens W, Damman K, Testani JM, Martens P, Mueller C, Lassus J et al. Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2020;22 (4):584-603. DOI: 10.1002/ejhf.1697Damman K, Valente MAE, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. European Heart Journal. 2014;35 (7):455-69. DOI: 10.1093/eurheartj/eht386Damman K, Valente MAE, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. European Heart Journal. 2014;35 (7):455-69. DOI: 10.1093/eurheartj/eht386Авдошина С.В., Ефремовцева М.А., Виллевальде С.В., Кобалава Ж.Д. Оценка риска развития острого повреждения почек у больных с острой сердечно-сосудистой патологией без инвазивного вмешательства. Кардиология. 2019;59 (12S): 46-56. DOI: 10.18087/cardio.n466Avdoshina S.V., Efremovtseva M.A., Villevalde S.V., Kobalava Zh.D. Risk assessment of acute kidney injury in patients with acute cardiovascular disease without invasive intervention. Kardiologiia. 2020;59 (12S): 46-56. DOI: 10.18087/cardio.n466Damman K, Tang WHW, Testani JM, McMurray JJV. Terminology and definition of changes renal function in heart failure. European Heart Journal. 2014;35 (48):3413-6. DOI: 10.1093/eurheartj/ehu320Damman K, Tang WHW, Testani JM, McMurray JJV. Terminology and definition of changes renal function in heart failure. European Heart Journal. 2014;35 (48):3413-6. DOI: 10.1093/eurheartj/ehu320Damman K, Testani JM. The kidney in heart failure: an update. European Heart Journal. 2015;36 (23):1437-44. DOI: 10.1093/eurheartj/ehv010Damman K, Testani JM. The kidney in heart failure: an update. European Heart Journal. 2015;36 (23):1437-44. DOI: 10.1093/eurheartj/ehv010Кобалава Ж.Д., Виллевальде С.В., Ефремовцева М.А. Основы кардиоренальной медицины. - М.: ГЭОТАР-Медиа, 2014. - 256с. ISBN 978-5-9704-3040-8Kobalava Zh.D., Villevalde S.V., Efremovtseva M.A. Fundamentals of cardiorenal medicine. Kobalava Zh.D., Moiseev S.V., editors -M.: GEOTAR-Media;2014. - 256 p. ISBN 978-5-9704-3040-8Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2016;29 (4):277-314. DOI: 10.1016/j.echo.2016.01.011Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2016;29 (4):277-314. DOI: 10.1016/j.echo.2016.01.011Овчинников А.Г., Азизова А.Г., Масенко В.П., Шаталина Л.С., Агеев Ф.Т. Влияние петлевых диуретиков на клиническое течение, давление наполнения левого желудочка у больных с компенсированной СНСФВ и высоким давлением наполнения ЛЖ. Журнал Сердечная Недостаточность. 2012;13 (6):320-33Ovchinnikov A.G., Azizova A.G., Masenko V.P., Shatalina L. S., Ageev F.T. The effect of loop diuretics on the clinical course, the filling pressure of the left ventricle in patients with compensated NSFW and high filling pressure of the LV. Russian Heart Failure Journal. 2012;13 (6):320-33.López B, González A, Beaumont J, Querejeta R, Larman M, Díez J. Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients with Chronic Heart Failure. Journal of the American College of Cardiology. 2007;50 (9):859-67. DOI: 10.1016/j.jacc.2007.04.080López B, González A, Beaumont J, Querejeta R, Larman M, Díez J. Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients with Chronic Heart Failure. Journal of the American College of Cardiology. 2007;50 (9):859-67. DOI: 10.1016/j.jacc.2007.04.080Овчинников А.Г., Ожерельева М.В., Масенко В.П., Агеев Ф.Т. Структурнофункциональные особенности течения компенсированного гипертонического сердца и факторы его неблагоприятного прогноза. Сердце: журнал для практикующих врачей. 2017;16 (3):185-96Ovchinnikov A.G., Ozhereleva M.V., Masenko V.P., Ageev F.T. Structure and function features and adverse prognostic factors of compensated hypertensive heart disease. Russian Heart Journal. 2017;16 (3):185-96.Ивашкин В.Т., Маевская М.В., Павлов Ч.С., Федосьина Е.А., Бессонова Е.Н., Пирогова И.Ю. и др. Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по лечению осложнений цирроза печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26 (4):71-102Ivashkin V.T., Mayevskaya M.V., Pavlov Ch. S., Fedosyina E.A., Bessonova E.N., Pirogova I.Yu. et al. Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26 (4):71-102.Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology. 2018;69 (2):406-60. DOI: 10.1016/j.jhep.2018.03.024Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology. 2018;69 (2):406-60. DOI: 10.1016/j.jhep.2018.03.024Masuda E, Ozsvath K, Vossler J, Woo K, Kistner R, Lurie F et al. The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology. Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2020;8 (4):505-525.e4. DOI: 10.1016/j.jvsv.2020.02.001Masuda E, Ozsvath K, Vossler J, Woo K, Kistner R, Lurie F et al. The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology. Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2020;8 (4):505-525.e4. DOI: 10.1016/j.jvsv.2020.02.001Perrin M, Eklof B, van Rij A, Labropoulos N, Vasquez M, Nicolaides A et al. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. International Angiology. 2016;35 (4):374-98. PMID: 27081866Perrin M, Eklof B, van Rij A, Labropoulos N, Vasquez M, Nicolaides A et al. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. International Angiology. 2016;35 (4):374-98. PMID: 27081866Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs--UIP consensus document. Part I. Basic principles. European Journal of Vascular and Endovascular Surgery. 2006;31 (1):83-92. DOI: 10.1016/j.ejvs.2005.07.019Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs--UIP consensus document. Part I. Basic principles. European Journal of Vascular and Endovascular Surgery. 2006;31 (1):83-92. DOI: 10.1016/j.ejvs.2005.07.019Alsheekh A, Hingorani A, Marks N, Ostrozhynskyy Y, Ascher E. Clinical correlation with failure of endovenous therapy for leg swelling. Vascular. 2017;25 (3):249-52. DOI: 10.1177/1708538116667325Alsheekh A, Hingorani A, Marks N, Ostrozhynskyy Y, Ascher E. Clinical correlation with failure of endovenous therapy for leg swelling. Vascular. 2017;25 (3):249-52. DOI: 10.1177/1708538116667325Huang X, Dorhout Mees E, Vos P, Hamza S, Braam B. Everything we always wanted to know about furosemide but were afraid to ask. American Journal of Physiology-Renal Physiology. 2016;310 (10):F958-71. DOI: 10.1152/ajprenal.00476.2015Huang X, Dorhout Mees E, Vos P, Hamza S, Braam B. Everything we always wanted to know about furosemide but were afraid to ask. American Journal of Physiology-Renal Physiology. 2016;310 (10):F958-71. DOI: 10.1152/ajprenal.00476.2015Stücker M, Danneil O, Dörler M, Hoffmann M, Kröger E, Reich‐Schupke S. Safety of a compression stocking for patients with chronic venous insufficiency (CVI) and peripheral artery disease (PAD). Journal der Deutschen Dermatologischen Gesellschaft. 2020;18 (3):207-13. DOI: 10.1111/ddg.14042Stücker M, Danneil O, Dörler M, Hoffmann M, Kröger E, Reich‐Schupke S. Safety of a compression stocking for patients with chronic venous insufficiency (CVI) and peripheral artery disease (PAD). Journal der Deutschen Dermatologischen Gesellschaft. 2020;18 (3):207-13. DOI: 10.1111/ddg.14042Lichota A, Gwozdzinski L, Gwozdzinski K. Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency. European Journal of Medicinal Chemistry. 2019;176:68-91. DOI: 10.1016/j.ejmech.2019.04.075Lichota A, Gwozdzinski L, Gwozdzinski K. Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency. European Journal of Medicinal Chemistry. 2019;176:68-91. DOI: 10.1016/j.ejmech.2019.04.075Garza R, Skoracki R, Hock K, Povoski SP. A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies. BMC cancer. 2017;17 (1):468. DOI: 10.1186/s12885-017-3444-9Garza R, Skoracki R, Hock K, Povoski SP. A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies. BMC cancer. 2017;17 (1):468. DOI: 10.1186/s12885-017-3444-9Polomska AK, Proulx ST. Imaging technology of the lymphatic system. Advanced Drug Delivery Reviews. 2020; S0169-409X (20) 30124-1. [Epub ahead of print. PMID: 32891679]. DOI: 10.1016/j.addr.2020.08.013Polomska AK, Proulx ST. Imaging technology of the lymphatic system. Advanced Drug Delivery Reviews. 2020; S0169-409X (20) 30124-1. [Epub ahead of print. PMID: 32891679]. DOI: 10.1016/j.addr.2020.08.013Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology. 2020;53 (1):3-19. PMID: 32521126Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology. 2020;53 (1):3-19. PMID: 32521126Lennie TA, Song EK, Wu J-R, Chung ML, Dunbar SB, Pressler SJ et al. Three gram sodium intake is associated with longer event-free survival only in patients with advanced heart failure. Journal of Cardiac Failure. 2011;17 (4):325-30. DOI: 10.1016/j.cardfail.2010.11.008Lennie TA, Song EK, Wu J-R, Chung ML, Dunbar SB, Pressler SJ et al. Three gram sodium intake is associated with longer event-free survival only in patients with advanced heart failure. Journal of Cardiac Failure. 2011;17 (4):325-30. DOI: 10.1016/j.cardfail.2010.11.008Parrinello G, Greene SJ, Torres D, Alderman M, Bonventre JV, Di Pasquale P et al. Water and Sodium in Heart Failure: A Spotlight on Congestion. Heart Failure Reviews. 2015;20 (1):13-24. DOI: 10.1007/s10741-014-9438-7Parrinello G, Greene SJ, Torres D, Alderman M, Bonventre JV, Di Pasquale P et al. Water and Sodium in Heart Failure: A Spotlight on Congestion. Heart Failure Reviews. 2015;20 (1):13-24. DOI: 10.1007/s10741-014-9438-7Li Y, Fu B, Qian X. Liberal Versus Restricted Fluid Administration in Heart Failure Patients: A Systematic Review and Meta-Analysis of Randomized Trials. International Heart Journal. 2015;56 (2):192- 5. DOI: 10.1536/ihj.14-288Li Y, Fu B, Qian X. Liberal Versus Restricted Fluid Administration in Heart Failure Patients: A Systematic Review and Meta-Analysis of Randomized Trials. International Heart Journal. 2015;56 (2):192- 5. DOI: 10.1536/ihj.14-288Dunlay SM, Gheorghiade M, Reid KJ, Allen LA, Chan PS, Hauptman PJ et al. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. European Journal of Heart Failure. 2010;12 (4):367-74. DOI: 10.1093/eurjhf/hfq019Dunlay SM, Gheorghiade M, Reid KJ, Allen LA, Chan PS, Hauptman PJ et al. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. European Journal of Heart Failure. 2010;12 (4):367-74. DOI: 10.1093/eurjhf/hfq019Jones CD, Holmes GM, DeWalt DA, Erman B, Wu J-R, Cene CW et al. Selfreported recall and daily diary-recorded measures of weight monitoring adherence: associations with heart failure-related hospitalization. BMC Cardiovascular Disorders. 2014;14 (1):12. DOI: 10.1186/1471-2261-14-12Jones CD, Holmes GM, DeWalt DA, Erman B, Wu J-R, Cene CW et al. Selfreported recall and daily diary-recorded measures of weight monitoring adherence: associations with heart failure-related hospitalization. BMC Cardiovascular Disorders. 2014;14 (1):12. DOI: 10.1186/1471-2261-14-12

The authors declare that there are no conflicts of interest present.